13_cis_retinoic_acid
  MOE2009           3D

 22 22  0  0  0  0  0  0  0  0999 V2000
   10.6160    5.4820   -0.2300 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.9350    3.3080   -0.3420 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1650   -3.7930   -0.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9360   -5.2870   -0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1970   -6.0950   -0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4270   -3.2930    0.2730 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2930   -5.6270    0.5190 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3720   -4.1470    0.7160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9180   -3.1060    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2620   -3.5100   -1.8950 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4900   -1.8530    0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5940   -3.7230    1.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5660   -1.0700    0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5800    0.3580    0.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3000    1.0310    0.8560 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7270    1.0260    0.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8760    2.4440    0.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0420    3.0690    0.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2550    4.4870    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0830    5.3300    0.7850 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4270    5.0940    0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7040    4.4870   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 22  1  0  0  0  0
  2 22  2  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  3  9  1  0  0  0  0
  3 10  1  0  0  0  0
  4  5  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  2  0  0  0  0
  6 11  1  0  0  0  0
  7  8  1  0  0  0  0
  8 12  1  0  0  0  0
 11 13  2  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 14 16  2  0  0  0  0
 16 17  1  0  0  0  0
 17 18  2  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 19 21  2  0  0  0  0
 21 22  1  0  0  0  0
M  END
>  <ID>
13_cis_retinoic_acid

>  <PRIMARY_SOM>
7

>  <Citation>
Marill et al.,Biochem. Pharmacol.,63,933,2002

$$$$
1_2-dibromoethane
  MOE2009           3D

  4  3  0  0  0  0  0  0  0  0999 V2000
   -0.4080   -0.0260    0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0860   -0.1780    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8800   -0.3030    1.8020 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -1.2020   -1.8040    0.3000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  4  1  0  0  0  0
  2  3  1  0  0  0  0
M  END
>  <ID>
1_2-dibromoethane

>  <PRIMARY_SOM>
1 2 3 4

>  <Citation>
Wormhoudt et al., Chemico-Biological Interactions, 1996, 101,175-192

>  <DOI>
10.1016/0009-2797(96)03723-4

$$$$
2-2prime-4-5-5prime-pentachlorobiphenyl
  MOE2009           3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    1.2380    0.6400    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4750    1.4960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0230    1.2590    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2460    0.5850    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6790    1.5360    0.0040 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.2490   -0.7980    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6850   -1.7430    0.0020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.0340   -1.4680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1880   -0.7740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5590   -1.8280   -0.0020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.7350    0.8760   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9470    1.5630   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4210    0.6900   -0.0020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.9600    2.9430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7440    3.6100    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5240    2.9120    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1490    3.9640    0.0020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  9  2  0  0  0  0
  2 11  1  0  0  0  0
  2 16  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  4  6  1  0  0  0  0
  6  7  1  0  0  0  0
  6  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
 12 14  1  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
M  END
>  <ID>
2-2prime-4-5-5prime-pentachlorobiphenyl

>  <PRIMARY_SOM>
14

>  <Citation>
McGraw and Waller,Biochem. Biophys. Res. Comm.,344,129,2006

>  <DOI>
10.1016/j.bbrc.2006.03.122

$$$$
2-methoxyacetophenone
  MOE2009           3D

 11 11  0  0  0  0  0  0  0  0999 V2000
    2.5210    0.6930    2.8910 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5390    0.8310    1.7900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5860    1.4520    1.9460 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2190    0.2300    0.4820 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9780    0.4980   -0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6680   -0.0530   -1.3520 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5890   -0.8720   -2.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8270   -1.1400   -1.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1500   -0.5740   -0.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3360   -0.9040    0.4200 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4280   -0.2400   -0.2170 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  2  0  0  0  0
  2  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  2  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
M  END
>  <ID>
2-methoxyacetophenone

>  <PRIMARY_SOM>
11

>  <Citation>
T. Su et al., Cancer Res., 2000, 60, 5074-5079

$$$$
2_6-dichlorobenzonitrilie
  MOE2009           3D

 10 10  0  0  0  0  0  0  0  0999 V2000
    1.1610    2.4190    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6980    3.2160    0.0130 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.0460    3.1340    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2530    2.4190    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7900    3.2150    0.0130 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.2510    1.0200    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0460    0.3220    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1600    1.0200    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0460    4.5690    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0460    5.7290    0.0140 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  8  2  0  0  0  0
  3  4  2  0  0  0  0
  3  9  1  0  0  0  0
  4  5  1  0  0  0  0
  4  6  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  9 10  3  0  0  0  0
M  END
>  <ID>
2_6-dichlorobenzonitrilie

>  <PRIMARY_SOM>
6 7 8

>  <Citation>
X. Ding et al., Mol. Pharmacol., 1996, 49, 1113-1121

$$$$
2n_propylquinoline
  MOE2009           3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4130    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2400   -0.6710   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3940    0.0490   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3730    1.4430   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1940    2.1230    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2570    2.0780    0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1480   -0.6850    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3940    1.3220    0.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3050   -0.0680    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5720   -0.8850    0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5640   -1.8500   -1.1530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8500   -2.6800   -1.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  2  8  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  9  2  0  0  0  0
  8 10  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
2n_propylquinoline

>  <PRIMARY_SOM>
11

>  <SECONDARY_SOM>
13

>  <Citation>
Belliard et al.,Xenobiotica,33,341,2003

$$$$
3-cyano-7-ethoxycoumarin
  MOE2009           3D

 16 17  0  0  0  0  0  0  0  0999 V2000
    1.3100    0.6530    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1280    1.3740   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0770    0.6830   -0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2000    1.4530   -0.3410 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3710    0.6510   -0.4520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5570    1.5720   -0.5980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0800   -0.7150   -0.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1140   -1.4240   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3160   -0.7340    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5750   -1.4310    0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7190   -0.7520    0.3420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7390    0.7200    0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7830    1.3540    0.4150 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5140    1.3700    0.1700 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9410   -1.4600    0.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9280   -2.0590    0.6060 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  2  0  0  0  0
  1 14  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 11 15  1  0  0  0  0
 12 13  2  0  0  0  0
 12 14  1  0  0  0  0
 15 16  3  0  0  0  0
M  END
>  <ID>
3-cyano-7-ethoxycoumarin

>  <PRIMARY_SOM>
5

>  <Citation>
Ekins et al., J. Pharmacol. Exp. Ther. 1998,286,1253-1259

$$$$
3-methoxy-4-trifluoromethylcoumarin
  MOE2009           3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    1.2810    0.6620    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1060    1.3820   -0.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0920    0.6950   -0.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2040    1.4660   -0.5690 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3670    0.6630   -0.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0980   -0.7000   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0880   -1.4050   -0.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2970   -0.7310    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5660   -1.4230    0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6140   -2.9130    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8410   -3.4180    1.2990 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8700   -3.3870    0.5160 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1840   -3.4700   -0.8570 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.6670   -0.6850    0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6810    0.7770    0.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7240    1.4010    0.5360 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4630    1.4080    0.1760 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  2  0  0  0  0
  1 17  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  4  5  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 14  2  0  0  0  0
 10 11  1  0  0  0  0
 10 12  1  0  0  0  0
 10 13  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 15 17  1  0  0  0  0
M  END
>  <ID>
3-methoxy-4-trifluoromethylcoumarin

>  <PRIMARY_SOM>
5

>  <Citation>
Stresser et al.,Drug Metab. Disp.,30,845,2002

>  <DOI>
10.1124/dmd.30.7.845

$$$$
3-methylindole
  MOE2009           2D

 10 11  0  0  0  0  0  0  0  0999 V2000
    0.8640    0.9810    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3490    0.3140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8640   -0.3540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0800   -0.0990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6350   -0.5110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3490   -0.0990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3490    0.7260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6350    1.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0800    0.7260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1190   -1.1380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3 10  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  2  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
3-methylindole

>  <PRIMARY_SOM>
2

>  <SECONDARY_SOM>
10

>  <Citation>
Thornton-Manning, J.; Appleton, J.L.; Gonzalez, F.J.; Yost, G.S. Metabolism of 3-Methylindole by Vaccinia-Expressed P450 Enzymes: Correlation of 3-Methyleneindolenine Formation and Protein-, Binding. J. Pharmacol. Exp. Ther. 1999, 276, 21~29.

$$$$
4-nitroanisole
  MOE2009           3D

 11 11  0  0  0  0  0  0  0  0999 V2000
   -0.0580    3.4920   -0.9100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9940    4.1700   -0.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0320    3.4740    0.5070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1330    2.0870    0.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2030    1.3990   -0.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1910    0.0510   -0.6710 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2200   -0.7200   -0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1700    2.1080   -1.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8870    5.6220    0.0430 N   0  3  0  0  0  0  0  0  0  0  0  0
   -1.7350    6.1850    0.7500 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0440    6.2020   -0.5330 O   0  5  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  2  0  0  0  0
  2  3  2  0  0  0  0
  2  9  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  8  1  0  0  0  0
  6  7  1  0  0  0  0
  9 10  2  0  0  0  0
  9 11  1  0  0  0  0
M  CHG  1   9   1
M  CHG  1  11  -1
M  END
>  <ID>
4-nitroanisole

>  <PRIMARY_SOM>
7

>  <Citation>
B.C. Jones et al., Xenobiotica, 1997, 27, 1025-1037

$$$$
5-MOP
  MOE2009           3D

 16 18  0  0  0  0  0  0  0  0999 V2000
    1.2620    0.6470   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0850    1.3940   -0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0860    0.6390   -0.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1380   -0.7510   -0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0770   -1.4710    0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2850   -0.7470    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5770   -1.4100    0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7050   -0.7040    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7070    0.7580    0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7580    1.3890    0.1030 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4690    1.3850    0.0180 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3400    1.1610   -0.2050 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2110    0.1160   -0.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5210   -1.0720   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1750   -2.8520    0.0680 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9170   -3.4230    0.7770 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1 11  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3 12  1  0  0  0  0
  4  5  2  0  0  0  0
  4 14  1  0  0  0  0
  5  6  1  0  0  0  0
  5 15  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
  9 11  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  2  0  0  0  0
 15 16  1  0  0  0  0
M  END
>  <ID>
5-MOP

>  <PRIMARY_SOM>
13 14

>  <Citation>
L.L. Koenigs and W.F. Trager, Biochemistry, 37, 10047-10061

$$$$
6-aminochrysene
  MOE2009           3D

 19 22  0  0  0  0  0  0  0  0999 V2000
    3.9590   -0.3410    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9710   -1.7600    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7300    0.3610   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1470    0.4000    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7200    1.7790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7470   -2.4650   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1580   -2.5120    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9400    2.4970    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1550    1.7960    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4000    2.4610    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5400   -0.3830   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5430   -1.7730   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7310   -3.8600   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1380   -3.9060    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5190    2.5120   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9080    3.9000    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9220   -4.5790   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5060    3.9040   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7050    4.6010    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  1  0  0  0  0
  3  5  1  0  0  0  0
  3 11  2  0  0  0  0
  4  9  2  0  0  0  0
  5  8  2  0  0  0  0
  5 15  1  0  0  0  0
  6 12  2  0  0  0  0
  6 13  1  0  0  0  0
  7 14  2  0  0  0  0
  8  9  1  0  0  0  0
  8 16  1  0  0  0  0
  9 10  1  0  0  0  0
 11 12  1  0  0  0  0
 13 17  2  0  0  0  0
 14 17  1  0  0  0  0
 15 18  2  0  0  0  0
 16 19  2  0  0  0  0
 18 19  1  0  0  0  0
M  END
>  <ID>
6-aminochrysene

>  <PRIMARY_SOM>
10

>  <Citation>
Yun et al.,Mol. Pharma.,40,679,1991

$$$$
7-ethoxycoumarin
  MOE2009           3D

 14 15  0  0  0  0  0  0  0  0999 V2000
    1.3350    0.6350    0.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1530    1.3550   -0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0500    0.6620   -0.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1730    1.4310   -0.3300 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3420    0.6270   -0.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5300    1.5460   -0.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0530   -0.7360   -0.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1400   -1.4460   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3410   -0.7550    0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5980   -1.4580    0.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7280   -0.7630    0.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7550    0.7030    0.3280 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8120    1.3130    0.4350 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5360    1.3580    0.1850 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  2  0  0  0  0
  1 14  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 12 14  1  0  0  0  0
M  END
>  <ID>
7-ethoxycoumarin

>  <PRIMARY_SOM>
5

>  <SECONDARY_SOM>
11

>  <Citation>
Yun et al.,J. Bio. Chem.,280,12279,2005
T. Shimada, F. Tsumura, H. Yamazaki, Drug Metab. Dispos. 1999, 27, 1274-1280.

>  <DOI>
10.1074/jbc.M411019200

$$$$
7-hydroxy-delta_8_tetrahydrocannabinol
  MOE2009           3D

 24 26  0  0  1  0  0  0  0  0999 V2000
   -1.7450   -1.9170    0.7430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9230   -1.1120    0.2230 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.5030   -0.0560   -0.7820 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.2010    0.5890   -0.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7160    1.7130   -1.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4960    2.3110   -0.7830 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2710    1.7820    0.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8170    0.6470    0.9110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3950    0.0450    0.5610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7110   -1.0780    1.2740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6470    0.9280   -1.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9690    0.2560   -1.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1550   -1.0400   -0.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0910   -1.9160   -0.3430 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.4150    2.2640   -2.1570 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5660    2.3890    0.6690 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2920    3.1740   -0.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8920    2.2560   -1.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5990    3.0740   -2.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1970    2.1570   -3.5280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0760    1.0920   -1.7180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1470   -2.8090   -0.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1520   -2.8040    1.9020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6560   -2.7510    0.6490 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 10  1  0  0  0  0
  1 22  1  0  0  0  0
  1 23  1  0  0  0  0
  2  3  1  0  0  0  0
  2 14  1  0  0  0  0
  3  4  1  0  0  0  0
  3 11  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  2  0  0  0  0
  5  6  2  0  0  0  0
  5 15  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  7 16  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 12 21  1  0  0  0  0
 13 14  1  0  0  0  0
 14 24  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
7-hydroxy-delta_8_tetrahydrocannabinol

>  <PRIMARY_SOM>
14

>  <Citation>
Matsunaga, T.; Kishi, N.; Higuchi, S.; Watanabe, K.; Ohshima, T.; Yamamoto, I. CYP3A4 is a Major Isoform Responsible for Oxidation of 7-Hydroxy-Delta(8)-Tetrahydrocannabinol to 7-Oxo-Delta(8)-Tetrahydrocannabinol in Human Liver Microsomes. Drug Metab. Dispos. 2000, 28, 1291~1296.

$$$$
7-methoxycoumarin
  MOE2009           2D

 13 14  0  0  0  0  0  0  0  0999 V2000
    6.3580   -1.0350    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660   -1.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1280   -1.0240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4640    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4640   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5980   -1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5980    1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3580    1.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2640    0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2640   -0.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0  0  0  0
  1 12  1  0  0  0  0
  2  8  1  0  0  0  0
  2 13  1  0  0  0  0
  3 12  2  0  0  0  0
  4  5  2  0  0  0  0
  4  7  1  0  0  0  0
  4 10  1  0  0  0  0
  5  6  1  0  0  0  0
  6  8  2  0  0  0  0
  7  9  2  0  0  0  0
  8  9  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
7-methoxycoumarin

>  <PRIMARY_SOM>
13

>  <SECONDARY_SOM>
11

>  <Citation>
Yun et al.,J. Bio. Chem.,280,12279,2005

>  <DOI>
10.1074/jbc.M411019200

$$$$
8-MOP
  MOE2009           3D

 16 18  0  0  0  0  0  0  0  0999 V2000
    1.2410    0.6770    0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0420    1.4120    0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1510    2.7840    0.2330 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1150    3.4260    0.2330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1240    0.6400   -0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1280   -0.7490   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0950   -1.4410   -0.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2780   -0.7100   -0.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5530   -1.3970   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6830   -0.7040    0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6940    0.7540    0.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7490    1.3690    0.3200 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4600    1.3930    0.2160 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4110    1.0990   -0.0380 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2320    0.0220   -0.1730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4880   -1.1340   -0.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  2  0  0  0  0
  1 13  1  0  0  0  0
  2  3  1  0  0  0  0
  2  5  2  0  0  0  0
  3  4  1  0  0  0  0
  5  6  1  0  0  0  0
  5 14  1  0  0  0  0
  6  7  2  0  0  0  0
  6 16  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
 11 13  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
M  END
>  <ID>
8-MOP

>  <PRIMARY_SOM>
15 16

>  <Citation>
L.L. Koenigs and W.F. Trager, Biochemistry, 37, 10047-10061

$$$$
8-OH-efavirenz
  MOE2009           3D

 22 24  0  0  1  0  0  0  0  0999 V2000
   -1.8520   -4.1700   -0.4700 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.6250   -0.2560   -2.3270 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8430    1.3560   -2.2090 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.2810    1.7930   -1.9570 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0150    1.9860    0.3760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3180    3.6190    1.2220 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2210    1.5290    1.0160 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7500   -0.7470    1.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0240   -0.3270    0.6270 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5280   -1.7350    0.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1840    0.6660   -0.2070 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.5030   -0.2520    0.7670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9490   -0.2940    0.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4630    0.1600    0.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1190    0.1810    0.6660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3160    0.8970   -1.7190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8810   -1.6530   -0.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2030   -0.6710    0.9060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3500   -0.1790    1.4860 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1970    2.4430    0.8810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9570   -2.5080   -0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1180   -2.0170    0.5590 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 21  1  0  0  0  0
  2 16  1  0  0  0  0
  3 16  1  0  0  0  0
  4 16  1  0  0  0  0
  5 11  1  0  0  0  0
  5 20  1  0  0  0  0
  6 20  2  0  0  0  0
  7 15  1  0  0  0  0
  7 20  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
  8 12  1  0  0  0  0
  9 10  1  0  0  0  0
 11 13  1  0  0  0  0
 11 14  1  0  0  0  0
 11 16  1  0  0  0  0
 12 14  3  0  0  0  0
 13 15  2  0  0  0  0
 13 17  1  0  0  0  0
 15 18  1  0  0  0  0
 17 21  2  0  0  0  0
 18 19  1  0  0  0  0
 18 22  2  0  0  0  0
 21 22  1  0  0  0  0
M  END
>  <ID>
8-OH-efavirenz

>  <PRIMARY_SOM>
8

>  <Citation>
Ward et al., J. Pharm. Exp. Ther., 2003, 306, 287-300

>  <DOI>
10.1124/jpet.103.049601

$$$$
9_anthraldehyde
  MOE2009           3D

 16 18  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4600   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1770    2.1810    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2650    2.1200    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2350   -0.6950   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2180   -0.6990   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4010    1.5080   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4100    1.3890    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4390    0.0450   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3880   -0.0040   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6200    2.2180    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6860   -0.6010   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7940    1.5330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8280    0.1400   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2630   -2.1100   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2290   -2.7390    0.0780 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  5 15  1  0  0  0  0
  6 10  2  0  0  0  0
  7  9  1  0  0  0  0
  7 11  1  0  0  0  0
  8 10  1  0  0  0  0
  9 12  1  0  0  0  0
 11 13  2  0  0  0  0
 12 14  2  0  0  0  0
 13 14  1  0  0  0  0
 15 16  2  0  0  0  0
M  END
>  <ID>
9_anthraldehyde

>  <PRIMARY_SOM>
15

>  <Citation>
Watanabe et al.,Drug Metab. Pharmacokin.,17,516,2002

$$$$
9_cis_retinoic_acid
  MOE2009           3D

 22 22  0  0  0  0  0  0  0  0999 V2000
   -0.2530    1.5870    0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2450    0.1890    0.2190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8320    2.3700   -0.4360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3920    2.0930    1.7160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4160   -0.4760    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3600   -2.4500   -0.7610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5600   -1.7300   -0.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8010   -1.8330   -0.3280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1720   -1.7850   -0.6820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4150   -1.8740   -0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9780   -2.5010   -0.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5910   -2.5420   -0.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5350   -0.5150   -1.0130 O   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7370   -2.3880   -1.0120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9040    3.8640   -0.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6640    3.5940    1.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4540    1.7260   -1.6480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5400    1.8360    2.9020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7120    1.3540    1.9430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6190    4.2870    1.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1410   -0.2820   -0.7790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1150   -2.6360   -0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  2  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  3 15  1  0  0  0  0
  3 17  1  0  0  0  0
  4 16  1  0  0  0  0
  4 18  1  0  0  0  0
  4 19  1  0  0  0  0
  5 10  1  0  0  0  0
  6  7  1  0  0  0  0
  6  9  2  0  0  0  0
  7 13  2  0  0  0  0
  7 14  1  0  0  0  0
  8 11  2  0  0  0  0
  8 12  1  0  0  0  0
  9 11  1  0  0  0  0
  9 21  1  0  0  0  0
 10 12  2  0  0  0  0
 10 22  1  0  0  0  0
 15 20  1  0  0  0  0
 16 20  1  0  0  0  0
M  END
>  <ID>
9_cis_retinoic_acid

>  <PRIMARY_SOM>
15

>  <Citation>
Marill et al.,Biochem. Pharmacol.,63,933,2002

$$$$
CP_125_611
  MOE2009           3D

 26 28  0  0  1  0  0  0  0  0999 V2000
    0.8370    0.6700   -1.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4420    1.2230   -1.2360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2500    1.1140   -0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6340    1.6900   -0.0550 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.7660    0.4380    1.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5120   -0.1160    1.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3130    0.0020   -0.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7090    3.2000   -0.3090 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.0000    4.0160    0.6700 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6120    4.1550    0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1560    5.0480    1.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1430    3.6880   -0.2540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0570    2.8440   -1.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8980    1.3690   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5250    0.9120   -0.9120 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9930    4.5450    2.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1390    3.1990    2.3250 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7010    5.3950    3.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5700    6.7730    2.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7380    7.2990    1.8660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6750    8.6620    1.8000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1970    9.1930    0.8100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4720    8.8030    1.0190 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.1960    8.8320   -0.4300 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1570   10.5420    0.8830 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0390    6.4310    1.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  8  1  0  0  0  0
  4 15  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
  8 12  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 16  1  0  0  0  0
 11 26  2  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  2  0  0  0  0
 18 19  1  0  0  0  0
 19 20  2  0  0  0  0
 20 21  1  0  0  0  0
 20 26  1  0  0  0  0
 21 22  1  0  0  0  0
 22 23  1  0  0  0  0
 22 24  1  0  0  0  0
 22 25  1  0  0  0  0
M  END
>  <ID>
CP_125_611

>  <PRIMARY_SOM>
8

>  <Citation>
Obach et al.,Drug Metab. Pharma.,22,336,2007

>  <DOI>
10.2133/dmpk.22.336

$$$$
CP_677_623
  MOE2009           3D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -1.8080    3.8640    0.5460 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4930    4.1910    0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2830    5.0800    0.9350 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2670    4.5630    1.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4880    3.2130    1.7300 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4910    2.8110    2.6570 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9700    5.4250    2.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7010    6.7920    2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7250    7.3130    1.7770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5390    8.6650    1.8480 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4560    9.2040    0.9890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6730    8.6930    1.2710 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1560    8.9780   -0.3070 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5090   10.5410    1.1800 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0220    6.4530    0.9370 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3 15  2  0  0  0  0
  4  5  1  0  0  0  0
  4  7  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
  9 15  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 11 14  1  0  0  0  0
M  END
>  <ID>
CP_677_623

>  <PRIMARY_SOM>
6

>  <Citation>
Obach et al.,Drug Metab. Pharma.,22,336,2007

>  <DOI>
10.2133/dmpk.22.336

$$$$
DDTC_Me
  MOE2009           3D

  9  8  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4610    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2410    2.2100    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0360    1.8580   -1.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0230   -0.5220    1.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1940    2.1190    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2390    1.4960    0.0210 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2180    3.8800    0.0290 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0040    4.1710    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  6  1  0  0  0  0
  2  5  1  0  0  0  0
  3  4  1  0  0  0  0
  6  7  2  0  0  0  0
  6  8  1  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
DDTC_Me

>  <PRIMARY_SOM>
6 7

>  <SECONDARY_SOM>
8

>  <Citation>
Madan et al.,Alcohol. Clin. Exp. Res.,22,1212,1998

>  <DOI>
10.111/j.1530-0277.1998.tb03901.x

$$$$
DETC_Me
  MOE2009           3D

  9  8  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4610    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2410    2.2100    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0360    1.8580   -1.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0230   -0.5220    1.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1940    2.1190    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2390    1.4960    0.0210 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2180    3.8800    0.0290 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0040    4.1710    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  6  1  0  0  0  0
  2  5  1  0  0  0  0
  3  4  1  0  0  0  0
  6  7  2  0  0  0  0
  6  8  1  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
DETC_Me

>  <PRIMARY_SOM>
8

>  <Citation>
Madan et al.,Drug Metab. Disp.,23,1153,1995

$$$$
ETBE
  MOE2009           3D

  7  6  0  0  0  0  0  0  0  0999 V2000
    0.2390    3.0960    1.8750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7560    2.3780    0.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2360    3.1010   -0.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2800    2.3860    0.6240 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2710    1.0400    0.6210 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0890    1.0380    0.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5990   -0.3640    0.9910 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  2  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
M  END
>  <ID>
ETBE

>  <PRIMARY_SOM>
6

>  <Citation>
J-Y. Hong et al., Arch. Toxicol., 1997, 71, 266-269

$$$$
FLU-1
  MOE2009           3D

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.1410    1.5410   -0.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6190    1.7140   -0.4590 N   0  3  0  0  0  0  0  0  0  0  0  0
    0.1160    0.0520   -0.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3090    2.3140   -0.3030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3570    4.2450    0.2480 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720    2.2130   -0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2810    3.7010   -0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3580    2.1900   -1.3300 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9030    0.7820    0.3010 O   0  5  0  0  0  0  0  0  0  0  0  0
   -1.1220    3.6010    0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1090   -0.4180   -0.8400 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.9720   -0.3770   -1.4370 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.4400   -0.6190    0.6650 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0590    4.3410    0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0  0  0  0
  1  4  2  0  0  0  0
  1  6  1  0  0  0  0
  2  4  1  0  0  0  0
  2  8  2  0  0  0  0
  2  9  1  0  0  0  0
  3 11  1  0  0  0  0
  3 12  1  0  0  0  0
  3 13  1  0  0  0  0
  4  7  1  0  0  0  0
  5 10  1  0  0  0  0
  6 10  2  0  0  0  0
  7 14  2  0  0  0  0
 10 14  1  0  0  0  0
M  CHG  1   2   1
M  CHG  1   9  -1
M  END
>  <ID>
FLU-1

>  <PRIMARY_SOM>
14

>  <SECONDARY_SOM>
5

>  <Citation>
Goda et al.,Drug Metab. Disp.,34,828,2006

>  <DOI>
10.1124/dmd.105.008623

$$$$
MNAN
  MOE2009           3D

  9  8  0  0  1  0  0  0  0  0999 V2000
   -2.2510    2.0570    2.6930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8990    1.4630    1.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4850    2.2410    0.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0350    3.7020    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5150    3.9140   -0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1350    3.1510   -1.1600 N   0  0  3  0  0  0  0  0  0  0  0  0
   -0.2920    3.6370   -2.4760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4480    3.1160   -1.0660 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8060    2.3720   -0.1460 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  6  8  1  0  0  0  0
  8  9  2  0  0  0  0
M  END
>  <ID>
MNAN

>  <PRIMARY_SOM>
5

>  <Citation>
S.C. Chen et al., Cancer Res., 1999, 59, 91-98

$$$$
MOCA
  MOE2009           3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    1.4910    0.2650    0.9740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8090    0.9260    1.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9910    0.0920    0.8360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8210    0.4520   -0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4120   -0.1620   -0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1800    0.1170   -1.9760 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.9900   -0.9690    0.5270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2320   -1.6070    0.3430 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3130   -1.1490    1.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9190   -0.5360    1.9600 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4920    0.1250   -0.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5960   -0.6540   -0.8070 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2140   -1.4740    0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3260   -2.2440   -0.2490 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7070   -1.5010    1.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4100   -2.4800    2.6760 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.6020   -0.7220    1.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  4  1  0  0  0  0
  1 10  2  0  0  0  0
  2  3  1  0  0  0  0
  3 11  1  0  0  0  0
  3 17  2  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7  9  2  0  0  0  0
  9 10  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 13 15  2  0  0  0  0
 15 16  1  0  0  0  0
 15 17  1  0  0  0  0
M  END
>  <ID>
MOCA

>  <PRIMARY_SOM>
8 14

>  <Citation>
Yun et al.,Carcinogenesis 13,217,1992

$$$$
MTBE
  MOE2009           3D

  6  5  0  0  0  0  0  0  0  0999 V2000
    0.2390    3.0960    1.8750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7560    2.3780    0.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2360    3.1010   -0.6320 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2800    2.3860    0.6240 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2710    1.0400    0.6210 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1540    1.0380    0.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  2  5  1  0  0  0  0
  5  6  1  0  0  0  0
M  END
>  <ID>
MTBE

>  <PRIMARY_SOM>
6

>  <Citation>
J-Y. Hong et al., Arch. Toxicol., 1997, 71, 266-269

$$$$
NDBA
  MOE2009           3D

 11 10  0  0  0  0  0  0  0  0999 V2000
   -1.4550    2.1300    0.4990 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4460    1.7980    1.1600 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3400    3.4350    0.4460 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0320    3.8240    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2240    4.0590   -0.5340 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4580    3.6160   -1.2990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6340    4.2180   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7490    4.0150   -1.4520 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1690    3.8390   -2.9200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4100    4.8020   -0.9630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8540    4.9110   -0.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7 10  1  0  0  0  0
  8  9  1  0  0  0  0
 10 11  1  0  0  0  0
M  END
>  <ID>
NDBA

>  <PRIMARY_SOM>
4 5

>  <Citation>
Hirotaka Kushida et al., Carcinogenesis, 21, 1227-1232, 2000

$$$$
NDEA
  MOE2009           3D

  7  6  0  0  0  0  0  0  0  0999 V2000
   -1.4200    2.1290    0.5220 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3850    1.7790    1.2100 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3770    3.4350    0.4020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0280    3.8820    0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4090    3.6260   -1.3550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2950    3.9590   -0.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7110    4.0650   -0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  6  1  0  0  0  0
  4  5  1  0  0  0  0
  6  7  1  0  0  0  0
M  END
>  <ID>
NDEA

>  <PRIMARY_SOM>
4 6

>  <Citation>
Bellec et al., Carcinogenesis, 1996, 17, 2029-2034

$$$$
NDMA
  MOE2009           3D

  5  4  0  0  0  0  0  0  0  0999 V2000
   -1.3690    2.2250    0.6680 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4320    1.6420    0.7580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3220    3.4600    0.1290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5280    4.0510   -0.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0640    4.2100    0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
M  END
>  <ID>
NDMA

>  <PRIMARY_SOM>
4 5

>  <Citation>
Hirotaka Kushida et al., Carcinogenesis, 21, 1227-1232, 2000

$$$$
NDPA
  MOE2009           3D

  9  8  0  0  0  0  0  0  0  0999 V2000
   -1.4550    2.1300    0.4990 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4460    1.7980    1.1600 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3400    3.4350    0.4460 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0320    3.8240    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2240    4.0590   -0.5340 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4580    3.6160   -1.2990 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8900    4.0580   -1.4690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6340    4.2180   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4940    4.8650   -1.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  5  8  1  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
NDPA

>  <PRIMARY_SOM>
4 5

>  <Citation>
Teiber et al., Carcinogenesis, 2000, 21, 1559-1566

$$$$
NMBA
  MOE2009           3D

  8  7  0  0  1  0  0  0  0  0999 V2000
   -1.4650    2.1740    0.6830 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6120    1.8440    1.0100 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3880    3.4570    0.4440 N   0  0  3  0  0  0  0  0  0  0  0  0
   -0.0270    3.8870    0.1680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2740    3.9110   -0.6180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4850    3.5250   -1.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9000    4.0240   -1.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4100    3.6640   -2.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
M  END
>  <ID>
NMBA

>  <PRIMARY_SOM>
4 5

>  <Citation>
Bellec et al., Carcinogenesis, 1996, 17, 2029-2034

$$$$
NMEA
  MOE2009           3D

  6  5  0  0  1  0  0  0  0  0999 V2000
   -1.3300    2.1530    0.6200 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4160    1.6620    0.9520 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4410    3.4330    0.3750 N   0  0  3  0  0  0  0  0  0  0  0  0
   -2.3870    3.7480   -0.6860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1580    4.0560    0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4000    3.7680   -1.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  5  6  1  0  0  0  0
M  END
>  <ID>
NMEA

>  <PRIMARY_SOM>
5

>  <SECONDARY_SOM>
4

>  <Citation>
Bellec et al., Carcinogenesis, 1996, 17, 2029-2034

$$$$
NMPhA
  MOE2009           3D

 10 10  0  0  1  0  0  0  0  0999 V2000
   -1.5100    2.0420    0.9170 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4110    1.5050    0.2630 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4190    3.3710    0.7070 N   0  0  3  0  0  0  0  0  0  0  0  0
   -0.4530    4.1740    1.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2810    4.1230   -0.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4610    3.6120    2.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4190    4.3880    2.9140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4820    5.7550    2.6720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5890    6.3410    1.7820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3640    5.5550    1.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  4 10  2  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
M  END
>  <ID>
NMPhA

>  <PRIMARY_SOM>
5

>  <Citation>
Hirotaka Kushida et al., Carcinogenesis, 21, 1227-1232, 2000

$$$$
NNK
  MOE2009           3D

 15 15  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.3940    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1450   -0.6570   -0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3060   -0.0310   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3740    1.3520   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2030    2.0870    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2940    2.1250    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2980    3.3380    0.0260 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5960    1.3670    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7630    2.3580    0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0850    1.5880    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2020    2.5370    0.0450 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6820    3.0880    1.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7620    2.8860   -1.0630 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6900    3.6740   -1.0540 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 12 14  1  0  0  0  0
 14 15  2  0  0  0  0
M  END
>  <ID>
NNK

>  <PRIMARY_SOM>
11

>  <SECONDARY_SOM>
13

>  <TERTIARY_SOM>
3

>  <Citation>
Smith et al.,Canc. Res.,52,1757,1992
Staretz et al.,Drug Metab. Disp.,25,154,1997

$$$$
NN_dimethyl_M_toluamide
  MOE2009           3D

 14 14  0  0  0  0  0  0  0  0999 V2000
   -0.1290    1.5810    1.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0030    1.2190    2.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1550    0.6120    2.9330 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1900    0.3630    2.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0710    0.7200    0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9180    1.3260    0.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3690    2.2250    0.6680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4320    1.6420    0.7580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3220    3.4600    0.1290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5280    4.0510   -0.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0640    4.2100    0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1280    4.8880    1.4860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2880    4.8280    0.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2940    0.2200    4.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3 14  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 11  1  0  0  0  0
 10 13  1  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
NN_dimethyl_M_toluamide

>  <PRIMARY_SOM>
11 10

>  <Citation>
Usmani et al.,Drug Metab. Disp.,30,289,2002

>  <DOI>
10.1124/dmd.30.3.289

$$$$
NPYR
  MOE2009           3D

  7  7  0  0  0  0  0  0  0  0999 V2000
   -1.5910    2.3840    0.9940 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2740    1.6010    0.3230 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2000    3.4020    0.2730 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2920    4.2830    1.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0360    5.6000    1.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6920    5.6230   -0.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3200    4.2480   -0.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
M  END
>  <ID>
NPYR

>  <PRIMARY_SOM>
4 7

>  <Citation>
Teiber et al., Carcinogenesis, 2000, 21, 1559-1566

$$$$
N_nitrosodiamylamine
  MOE2009           3D

 13 12  0  0  0  0  0  0  0  0999 V2000
   -0.0150    1.2860    0.0090 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0440   -0.6270    0.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2430    2.0350    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2940    2.0010    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6950    2.2890    1.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7460    2.2580   -1.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0100    3.0720    1.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0810    3.0050   -1.4100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4620    3.3250    2.8720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5330    3.2620   -2.8480 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7760    4.1080    2.8640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8680    4.0080   -2.8380 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  3  2  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
 10 12  1  0  0  0  0
 11 13  1  0  0  0  0
M  END
>  <ID>
N_nitrosodiamylamine

>  <PRIMARY_SOM>
10 11

>  <SECONDARY_SOM>
8 9

>  <TERTIARY_SOM>
4 5 6 7

>  <Citation>
Bellec et al.,Mutation Res.,377,199,1997

>  <DOI>
10.1016/S0027-5107(97)00073-0

$$$$
N_nitrosonornicotine
  MOE2009           3D

 13 14  0  0  1  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4260    2.0470   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6580    1.9870    1.2420 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2070   -0.7020   -1.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2350   -0.7070    1.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3420    3.2740    0.9460 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3230    2.7810    2.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1790   -2.0880   -1.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2560   -2.0260    1.1690 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0550   -2.7230    0.0680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8770    1.7570    1.5970 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3030    2.2110    2.6440 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  4 12  1  0  0  0  0
  5  9  1  0  0  0  0
  6 10  2  0  0  0  0
  7  8  1  0  0  0  0
  9 11  2  0  0  0  0
 10 11  1  0  0  0  0
 12 13  2  0  0  0  0
M  END
>  <ID>
N_nitrosonornicotine

>  <PRIMARY_SOM>
8

>  <Citation>
Patten et al.,Carcinogenesis,18,1623,1997

$$$$
ROX_M-4
  MOE2009           3D

 18 19  0  0  0  0  0  0  0  0999 V2000
    0.6160    1.0720    1.8610 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9590    1.4140    1.3680 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0300    1.6010   -0.1460 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6000    0.3340   -0.8840 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5880   -0.4860   -0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2270    0.4000    0.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0660    2.2380    2.4490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2920    1.8790    3.2650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4790    2.6090    3.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5900    2.2970    3.9120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5200    1.2570    4.8390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3450    0.5160    4.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4060   -0.4720    5.9330 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3460   -1.4270    5.9890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2180   -0.9830    6.9220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6830   -0.5450    8.3110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3380   -1.6290    9.0330 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2340    0.8400    4.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  1  0  0  0  0
  1  7  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 18  2  0  0  0  0
  9 10  2  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
 12 18  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
M  END
>  <ID>
ROX_M-4

>  <PRIMARY_SOM>
16

>  <Citation>
M. Sasaki et al., Arzneim.-Forsch/Drug Res., 2001, 51, 651-658

$$$$
SM-12502
  MOE2009           3D

 14 15  0  0  1  0  0  0  0  0999 V2000
    1.6960   -2.8490    1.5500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7930   -1.9350    0.7400 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.5880   -0.8650    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5930   -1.1120   -0.6480 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0270    0.3960    0.1560 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1860    0.5130    0.9440 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.3760   -1.0630    1.8140 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4160    0.8450    0.1370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3860    1.6960    0.6640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5270    2.0480    0.0280 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7250    1.5170   -1.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8370    0.6520   -1.8130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6700    0.3120   -1.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6210    1.5800   -0.4380 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  7  1  0  0  0  0
  3  4  2  0  0  0  0
  3  5  1  0  0  0  0
  5  6  1  0  0  0  0
  5 14  1  0  0  0  0
  6  7  1  0  0  0  0
  6  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 13  2  0  0  0  0
  9 10  2  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
SM-12502

>  <PRIMARY_SOM>
7

>  <Citation>
K-I. Nunoya et al., J. Pharm. Exp. Ther., 1996, 277, 768-774

$$$$
TAME
  MOE2009           3D

  7  6  0  0  0  0  0  0  0  0999 V2000
    0.6920    1.8740    2.4320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2090    1.1560    1.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6890    1.8790   -0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2020    3.3260   -0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2000    1.1630   -1.3210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7350    1.8810   -0.0760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2100    2.5440    1.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  3  6  1  0  0  0  0
  6  7  1  0  0  0  0
M  END
>  <ID>
TAME

>  <PRIMARY_SOM>
7

>  <Citation>
J-Y. Hong et al., Arch. Toxicol., 1997, 71, 266-269

$$$$
acetaminophen
  MOE2009           3D

 11 11  0  0  0  0  0  0  0  0999 V2000
    2.4050   -3.6550   -0.0050 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2420    2.2160   -0.0110 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9270    1.8530   -0.0200 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8460    0.4550   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5710   -0.1110   -0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9720   -0.3690   -0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4180   -1.4950   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8280   -1.7540   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5510   -2.3000   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0810    2.6090   -0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7400    4.0660   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  1  0  0  0  0
  2 10  2  0  0  0  0
  3  4  1  0  0  0  0
  3 10  1  0  0  0  0
  4  5  2  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  2  0  0  0  0
  7  9  2  0  0  0  0
  8  9  1  0  0  0  0
 10 11  1  0  0  0  0
M  END
>  <ID>
acetaminophen

>  <PRIMARY_SOM>
7 8

>  <SECONDARY_SOM>
1 3

>  <Citation>
Chen et al.,Chem. Res. Toxicol.,11,295,1998

>  <DOI>
10.1021/tx9701687

$$$$
aflatoxin_b1
  MOE2009           3D

 23 27  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.3860    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2040   -0.6810   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4070    0.0130   -0.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4210    1.3960   -0.0810 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2070    2.0940    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1520    3.5010    0.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0740    4.1330    0.3230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2890    3.3080    0.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2020    2.0440   -0.0060 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2320    4.5270   -0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5420    5.8930    0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0780    5.5710    0.3630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1490   -0.9870    0.0490 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.5000   -2.3480    0.4360 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.9510   -2.1740   -0.0480 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9880   -0.6960    1.2830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5620   -1.4860    2.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5390   -2.2880    1.8730 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8110    6.3780    0.5410 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2940    3.7290    1.0310 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5960    2.0690   -0.1410 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6320    1.0880   -0.2170 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1 10  1  0  0  0  0
  2  3  2  0  0  0  0
  2 14  1  0  0  0  0
  3  4  1  0  0  0  0
  3 16  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5 22  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  7 11  1  0  0  0  0
  8  9  1  0  0  0  0
  8 13  1  0  0  0  0
  9 10  1  0  0  0  0
  9 21  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 13 20  2  0  0  0  0
 14 15  1  0  0  0  0
 14 17  1  0  0  0  0
 15 16  1  0  0  0  0
 15 19  1  0  0  0  0
 17 18  2  0  0  0  0
 18 19  1  0  0  0  0
 22 23  1  0  0  0  0
M  END
>  <ID>
aflatoxin_b1

>  <PRIMARY_SOM>
23

>  <SECONDARY_SOM>
14

>  <TERTIARY_SOM>
11

>  <Citation>
X. Y. He, L. L. Tang, S. L. Wang, Q. S. Cai, J. S. Wang, J. Y. Hong, Int. J. Cancer 2006, 118, 2665-2671

>  <DOI>
10.1002/ijc.21665

$$$$
aminopyrine
  MOE2009           3D

 16 17  0  0  1  0  0  0  0  0999 V2000
    1.2340    0.6640   -0.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0720    1.3640    0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1000    0.6680    0.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1030   -0.7260    0.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0540   -1.4490    0.1170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0150   -2.8580    0.0910 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2180   -0.7300   -0.1530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0970   -3.6770    0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2410   -3.3550    0.6360 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6270   -5.1190    0.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4300   -6.2220    0.3620 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8290   -6.1260    0.7110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9350   -7.5700    0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6750   -5.0000   -0.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0860   -3.6910   -0.1960 N   0  0  3  0  0  0  0  0  0  0  0  0
    2.4120   -3.2500   -0.5120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  6 15  1  0  0  0  0
  8  9  2  0  0  0  0
  8 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 14  2  0  0  0  0
 11 12  1  0  0  0  0
 11 13  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
M  END
>  <ID>
aminopyrine

>  <PRIMARY_SOM>
12 13

>  <Citation>
Niwa et al.,Xenobiotica,29,187,1999

>  <DOI>
10.1080/004982599238731

$$$$
antipyrine
  MOE2009           3D

 14 15  0  0  1  0  0  0  0  0999 V2000
   -0.5220    2.9500    0.2050 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2640    0.5920   -0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2370   -0.4150   -0.1310 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4770    0.1550    0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1390    0.4060    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9410    1.8060    0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3900    1.4870    0.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9690   -1.7690   -0.5580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7370   -0.6370    0.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9960    1.4380   -0.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7270   -0.7690    0.5150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3860    1.2840   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1170   -0.9260    0.5490 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9470    0.0990    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  6  2  0  0  0  0
  2  3  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  4  1  0  0  0  0
  3  8  1  0  0  0  0
  4  7  2  0  0  0  0
  4  9  1  0  0  0  0
  5 10  2  0  0  0  0
  5 11  1  0  0  0  0
  6  7  1  0  0  0  0
 10 12  1  0  0  0  0
 11 13  2  0  0  0  0
 12 14  2  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
antipyrine

>  <PRIMARY_SOM>
7

>  <SECONDARY_SOM>
8

>  <TERTIARY_SOM>
9

>  <Citation>
Sharer et al.,Drug Metab. Disp.,24,487,1996

$$$$
arachidonic_acid
  MOE2009           3D

 22 21  0  0  0  0  0  0  0  0999 V2000
   10.1270    3.3080   -2.6290 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8510    4.8200   -0.9420 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8710    1.5580    1.4530 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7460    0.7020    1.9870 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6580    0.8720    0.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0100    1.4510    3.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8160    0.4310   -0.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1120    0.5960    3.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4170    1.7080   -0.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4690    0.6900    0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7050   -0.8280   -1.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4010   -1.9960   -0.6140 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6380    2.7370   -0.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2360   -0.3180    1.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4470   -2.3160   -0.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2990   -2.6660   -1.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2270   -1.6330    1.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4220   -2.2230   -0.3400 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6240   -2.7690   -1.4670 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5070   -3.3210    0.5000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1780   -3.2830    0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5920    3.7460   -1.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 22  1  0  0  0  0
  2 22  2  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7 11  2  0  0  0  0
  9 10  1  0  0  0  0
  9 13  1  0  0  0  0
 10 14  1  0  0  0  0
 11 12  1  0  0  0  0
 12 16  1  0  0  0  0
 13 22  1  0  0  0  0
 14 17  2  0  0  0  0
 15 17  1  0  0  0  0
 15 20  1  0  0  0  0
 16 19  2  0  0  0  0
 18 19  1  0  0  0  0
 18 21  1  0  0  0  0
 20 21  2  0  0  0  0
M  END
>  <ID>
arachidonic_acid

>  <PRIMARY_SOM>
6

>  <Citation>
Rifkind et al.,Arch. Biochem. Biophys.,320,380,1995

>  <DOI>
10.1016/0003-9861(95)90023-3

$$$$
barnidipine
  MOE2009           3D

 36 39  0  0  1  0  0  0  0  0999 V2000
   -3.1920    0.8540   -0.5490 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.9050    1.5800   -0.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2630   -0.5230    0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4370    1.6730   -0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6750    0.9230   -0.6740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9350    2.7700    0.4210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3650   -1.6340   -0.7680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2390   -0.7090    1.4600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3560    2.8570    0.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6840    1.1110   -0.8100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3400    1.1050    0.2030 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6260    0.2510   -1.6940 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1330    3.3970    0.7430 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7180    3.5590    0.7750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4400   -2.9080   -0.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3120   -1.9900    2.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5310    3.7280    0.6520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7210    1.3140    0.0340 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7240    0.4840   -1.8590 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5430    0.4770   -0.2170 C   0  0  3  0  0  0  0  0  0  0  0  0
   -3.4140   -3.0990    1.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5550   -4.0610   -1.0810 N   0  3  0  0  0  0  0  0  0  0  0  0
   -7.9200    0.7250   -0.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4610    0.1850    0.9590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3690    1.4200   -1.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6600   -3.8540   -2.2980 O   0  5  0  0  0  0  0  0  0  0  0  0
   -3.5460   -5.1820   -0.5540 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7850    0.6410    0.5090 N   0  0  3  0  0  0  0  0  0  0  0  0
    3.6950    0.7030   -0.9560 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7730   -0.3460    0.9100 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1810    0.1340    0.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7350    0.9570    1.7660 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9530   -0.2480   -0.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0500    1.3980    1.6480 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2690    0.1940   -0.4310 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8170    1.0170    0.5490 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  2  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  5 12  2  0  0  0  0
  6 13  1  0  0  0  0
  6 14  1  0  0  0  0
  7 15  1  0  0  0  0
  8 16  2  0  0  0  0
  9 13  1  0  0  0  0
  9 17  1  0  0  0  0
 10 18  1  0  0  0  0
 10 19  2  0  0  0  0
 11 20  1  0  0  0  0
 15 21  2  0  0  0  0
 15 22  1  0  0  0  0
 16 21  1  0  0  0  0
 18 23  1  0  0  0  0
 20 24  1  0  0  0  0
 20 25  1  0  0  0  0
 22 26  1  0  0  0  0
 22 27  2  0  0  0  0
 24 28  1  0  0  0  0
 25 29  1  0  0  0  0
 28 29  1  0  0  0  0
 28 30  1  0  0  0  0
 30 31  1  0  0  0  0
 31 32  2  0  0  0  0
 31 33  1  0  0  0  0
 32 34  1  0  0  0  0
 33 35  2  0  0  0  0
 34 36  2  0  0  0  0
 35 36  1  0  0  0  0
M  CHG  1  22   1
M  CHG  1  26  -1
M  END
>  <ID>
barnidipine

>  <PRIMARY_SOM>
30

>  <SECONDARY_SOM>
20

>  <TERTIARY_SOM>
1 13

>  <Citation>
Teramura et al.,Xenobiotica,27,885,1997

>  <DOI>
0049-8254/97

$$$$
bromodichloromethane
  MOE2009           2D

  4  3  0  0  0  0  0  0  0  0999 V2000
    0.0000   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140   -0.6190    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.7140   -0.6190    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.6190    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
M  END
>  <ID>
bromodichloromethane

>  <PRIMARY_SOM>
1 4

>  <Citation>
John W. Allis and Guangyu Zhao, Chemico-Biological Interactions 140 (2002) 137~153

$$$$
butadiene
  MOE2009           3D

  4  3  0  0  0  0  0  0  0  0999 V2000
   -1.0560    0.5700   -0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2970    0.0810   -0.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1170   -0.2560   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3470    0.2670    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  2  0  0  0  0
M  END
>  <ID>
butadiene

>  <PRIMARY_SOM>
1 2 3 4

>  <Citation>
R.J. Deuscher and A.A. Elfarra, Arch. Biochem. Biophys., 1994, 311, 342-349

>  <DOI>
10.1006/abbi.1994.1246

$$$$
butadiene_monoxide
  MOE2009           2D

  5  5  0  0  1  0  0  0  0  0999 V2000
   -0.5450    0.4820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5300    0.2860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1150   -0.2690    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.9690    0.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9920   -0.7500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  4  5  1  0  0  0  0
M  END
>  <ID>
butadiene_monoxide

>  <PRIMARY_SOM>
1 2

>  <Citation>
Krause and Elfarra,Arch. Biochem. Biophys.,337,176,1997

$$$$
chlorzoxazone
  MOE2009           3D

 11 12  0  0  0  0  0  0  0  0999 V2000
    1.3330    0.6250    0.2650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2120    1.4210    0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0080    0.7740   -0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5940   -1.3800   -0.3940 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.0710   -0.6280   -0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0710   -1.4210   -0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2530   -0.7460    0.1730 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5300   -1.2400    0.3190 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3560   -0.1320    0.4980 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5690   -0.1620    0.6630 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6250    1.0690    0.4690 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  1 11  1  0  0  0  0
  2  3  2  0  0  0  0
  3  5  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
  9 11  1  0  0  0  0
M  END
>  <ID>
chlorzoxazone

>  <PRIMARY_SOM>
3

>  <Citation>
T. Shimada, F. Tsumura, H. Yamazaki, Drug Metab. Dispos. 1999, 27, 1274-1280.

$$$$
cibenzoline
  MOE2009           3D

 20 23  0  0  1  0  0  0  0  0999 V2000
    0.1420    0.8450   -0.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2310   -0.6240    0.0650 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.2100    1.4970   -0.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3690    1.6740    0.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3480   -0.0400   -1.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0760   -1.3960    0.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8760    1.5740    1.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7710    2.0610   -1.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2640    2.9050    0.7830 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6540    1.2180   -0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6240   -1.8880    1.2060 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7980   -1.6840   -0.9830 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1140    2.2140    1.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0060    2.7050   -1.2200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4050    3.6570    1.0990 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8000    1.9630    0.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9660   -2.4040    0.8920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8740   -2.6260   -0.6260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6860    2.7760    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6780    3.1870    0.7580 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  6 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  8 14  2  0  0  0  0
  9 15  1  0  0  0  0
 10 16  2  0  0  0  0
 11 17  1  0  0  0  0
 12 18  1  0  0  0  0
 13 19  2  0  0  0  0
 14 19  1  0  0  0  0
 15 20  2  0  0  0  0
 16 20  1  0  0  0  0
 17 18  1  0  0  0  0
M  END
>  <ID>
cibenzoline

>  <PRIMARY_SOM>
17 18

>  <Citation>
Niwa et al.,Drug Metab. Disp.,28,1128,2000

$$$$
cisapride
  MOE2009           3D

 32 34  0  0  1  0  0  0  0  0999 V2000
    6.4190   -0.0900   -0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5750   -0.1140   -1.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6100   -0.9640   -0.7170 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4940   -1.7920    0.3870 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3410   -1.7680    1.1520 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3040   -0.9190    0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5060   -2.6230    0.7170 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.4020    0.7500   -0.6200 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3680    0.5450    0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1870    1.4650    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0800    1.2450    1.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0020    2.2180    0.8400 N   0  0  3  0  0  0  0  0  0  0  0  0
   -0.0620    1.8950    1.7970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    2.8670    1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7950    2.7230    0.2040 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.6650    2.9380   -0.8070 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.4740    1.9620   -0.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1550    2.7050   -2.1290 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3970    3.5420   -3.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3590    1.3820    0.0350 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6540    1.1530    0.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3540    2.0600    0.7390 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2200   -0.1950    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5700   -0.4350    0.4640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0930   -1.7060    0.3010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2820   -2.7350   -0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9420   -2.4920   -0.4590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4170   -1.2410   -0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9370   -3.7860   -1.0340 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -5.8080   -4.0130   -0.3230 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3570    0.5740    0.9140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6570    0.0190    1.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  8  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4  7  1  0  0  0  0
  5  6  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 12 17  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 20  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  1  0  0  0  0
 18 19  1  0  0  0  0
 20 21  1  0  0  0  0
 21 22  2  0  0  0  0
 21 23  1  0  0  0  0
 23 24  1  0  0  0  0
 23 28  2  0  0  0  0
 24 25  2  0  0  0  0
 24 31  1  0  0  0  0
 25 26  1  0  0  0  0
 26 27  2  0  0  0  0
 26 30  1  0  0  0  0
 27 28  1  0  0  0  0
 27 29  1  0  0  0  0
 31 32  1  0  0  0  0
M  END
>  <ID>
cisapride

>  <PRIMARY_SOM>
26

>  <Citation>
Desta et al.,J. Pharm. Exp. Thera.,298,508,2001

$$$$
clomethiazole
  MOE2009           3D

  9  9  0  0  0  0  0  0  0  0999 V2000
    0.3370   -0.1770    1.4270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9220   -0.5900    0.7540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8560    0.2380    0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1510   -0.7090   -0.4680 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3650   -2.1220    0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2210   -1.9430    0.7080 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8660    1.7320    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9290    2.2400   -1.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5370    1.8690   -2.7180 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  2  0  0  0  0
  2  6  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
clomethiazole

>  <PRIMARY_SOM>
7

>  <Citation>
C. Centerholt et al., Pharmacokin. Dispos., 2003, 59, 117-122

>  <DOI>
10.1007/s00228-003-0598-y

$$$$
cotinine
  MOE2009           3D

 13 14  0  0  1  0  0  0  0  0999 V2000
    1.1010    0.4970   -0.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2600    1.1810    0.5650 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9410    0.6130    0.8020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6970   -1.1270    0.6070 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.3420   -0.6050    0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4430   -1.2750   -0.5510 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8030   -0.7240   -0.8210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6530   -1.0620   -0.4790 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6860   -0.0250   -1.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5660   -2.1110   -0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5010   -2.3440   -1.1590 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2110   -2.8750    0.8410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7080   -2.6260    0.8400 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  2  0  0  0  0
  3  5  1  0  0  0  0
  4  5  1  0  0  0  0
  4  8  1  0  0  0  0
  4 13  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 10 11  2  0  0  0  0
 10 12  1  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
cotinine

>  <PRIMARY_SOM>
4

>  <SECONDARY_SOM>
9

>  <TERTIARY_SOM>
12

>  <Citation>
Murphy et al.,Chem. Res. Toxicol.12,639,1999

>  <DOI>
10.1021/tx990015e

$$$$
coumarin
  MOE2009           3D

 11 12  0  0  0  0  0  0  0  0999 V2000
    1.2980    0.6720    0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1140    1.4020    0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0950    0.7190   -0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1080   -0.6730   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0880   -1.3910   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2980   -0.7140   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5580   -1.4270   -0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6970   -0.7450    0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7300    0.7170    0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7950    1.3150    0.2970 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5080    1.3820    0.1950 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1 11  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
  9 11  1  0  0  0  0
M  END
>  <ID>
coumarin

>  <PRIMARY_SOM>
3

>  <Citation>
Lewis et al.,Toxic.,20,256,2006

>  <DOI>
10.1016/.tiv.2005.08.001

$$$$
cyclophosphamide
  MOE2009           3D

 14 14  0  0  1  0  0  0  0  0999 V2000
   -0.7780    0.0140   -0.1410 P   0  0  3  0  0  0  0  0  0  0  0  0
   -1.5870   -1.4430   -0.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8170   -0.0400    0.3800 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5790    1.0700    0.7120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7800    0.4520   -1.6500 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4060    1.2460   -0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5660   -1.1520   -0.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6400    2.7520   -0.2330 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.4840   -1.8010    2.2750 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.9730   -1.2560   -0.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6630   -0.1860    0.3980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9450    1.1760    0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6810   -2.3340    0.7690 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8940    1.2600    0.3570 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  2  0  0  0  0
  2 10  1  0  0  0  0
  3  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4 12  1  0  0  0  0
  6 14  1  0  0  0  0
  7 13  1  0  0  0  0
  8 14  1  0  0  0  0
  9 13  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
cyclophosphamide

>  <PRIMARY_SOM>
10

>  <Citation>
Roy et al.,Drug Metab. Disp.,27,655,1999

$$$$
decursinol_angelate
  MOE2009           3D

 24 26  0  0  1  0  0  0  0  0999 V2000
    1.2070    0.2150   -1.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2480    1.0880   -0.8530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0210    0.6030   -0.3550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2150   -0.7630   -0.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1940   -1.6760   -0.5080 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0280   -1.2310   -1.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9290   -2.0080   -1.2940 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0530    1.4800   -0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2700    0.9820    0.4270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4460   -0.3950    0.6000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4160   -1.2770    0.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3650    1.9430    0.7320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6900    1.2180    0.6760 C   0  0  3  0  0  0  0  0  0  0  0  0
   -6.7290    2.0860    1.1250 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6370   -0.0710    1.4860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9480   -0.8150    1.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4570    0.1930    2.9700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6050   -0.9650    1.0500 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2470    2.8220    0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3330    3.7080    0.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8260    3.8090    1.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4350    3.0860    3.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.9210    4.5630   -0.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8620    2.7720   -1.0510 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  6  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  8  2  0  0  0  0
  4  5  1  0  0  0  0
  4 11  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
  9 12  1  0  0  0  0
 10 11  1  0  0  0  0
 10 18  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 13 15  1  0  0  0  0
 14 19  1  0  0  0  0
 15 16  1  0  0  0  0
 15 17  1  0  0  0  0
 15 18  1  0  0  0  0
 19 20  1  0  0  0  0
 19 24  2  0  0  0  0
 20 21  2  0  0  0  0
 20 23  1  0  0  0  0
 21 22  1  0  0  0  0
M  END
>  <ID>
decursinol_angelate

>  <PRIMARY_SOM>
20 21

>  <Citation>
Yoo et al.,Drug Metab. Disp.,35,1759,2007

>  <DOI>
10.1124/dmd.107.016584

$$$$
diallyl_disulfide
  MOE2009           3D

  8  7  0  0  0  0  0  0  0  0999 V2000
   -0.1370   -0.0860   -0.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3690   -0.1380    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0900   -0.6460   -1.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7430   -0.6450   -0.4320 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4600   -1.3840   -2.1560 S   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1170   -1.3400   -1.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8520   -1.8640   -2.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0750   -1.8380   -2.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
M  END
>  <ID>
diallyl_disulfide

>  <PRIMARY_SOM>
4 5

>  <Citation>
Teyssier et al.,Drug Metab. Disp.,27,835,1999

$$$$
dibenzo_a_l_pyrene
  MOE2009           3D

 24 29  0  0  0  0  0  0  0  0999 V2000
   -1.8990   -1.1580    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8310   -2.5710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6090   -3.2180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5680   -2.4910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7680   -3.1940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9800   -2.5170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9990   -1.1290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2260   -0.4740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2750    0.9130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0900    1.6400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8300    1.0130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6280    1.7450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6200    1.0720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6880   -0.3670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5450   -1.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7860   -0.3940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9830   -3.3580    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2430   -2.7730    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3520   -1.3910    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1960   -0.6100    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7710    1.8830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7320    3.2750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5070    3.9150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6540    3.1520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 14  1  0  0  0  0
  1 20  2  0  0  0  0
  2  3  1  0  0  0  0
  2 17  2  0  0  0  0
  3  4  2  0  0  0  0
  4  5  1  0  0  0  0
  4 15  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7 16  2  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 11 16  1  0  0  0  0
 12 13  1  0  0  0  0
 12 24  2  0  0  0  0
 13 14  1  0  0  0  0
 13 21  2  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
 19 20  1  0  0  0  0
 21 22  1  0  0  0  0
 22 23  2  0  0  0  0
 23 24  1  0  0  0  0
M  END
>  <ID>
dibenzo_a_l_pyrene

>  <PRIMARY_SOM>
8

>  <SECONDARY_SOM>
17 18

>  <Citation>
Shou, M.; Krausz, K.W.; Gonzalez, F.J.; Gelboin, H.V. Metabolic Activation of the Potent Carcinogen Dibenzo[a,l ]pyrene by Human Recombinant Cytochromes P450, Lung and Liver Microsomes. Carcinogenesis 1996, 17, 2429~2433.

>  <DOI>
10.1093/carcin/17.11.2429

$$$$
diuron
  MOE2009           3D

 14 14  0  0  0  0  0  0  0  0999 V2000
    0.8090   -2.6710   -0.0070 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.4870   -4.5490    0.0090 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.1380    1.7270    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6970    3.5060   -0.0110 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8440    1.3530   -0.0080 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7950   -0.0450   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9820    2.1470   -0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5340   -0.6380   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9330   -0.8470    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3570    4.0370   -0.0180 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7780    4.4530   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4070   -2.0260   -0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8110   -2.2340    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5500   -2.8280    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  1  0  0  0  0
  2 14  1  0  0  0  0
  3  7  2  0  0  0  0
  4  7  1  0  0  0  0
  4 10  1  0  0  0  0
  4 11  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  2  0  0  0  0
  6  9  1  0  0  0  0
  8 12  1  0  0  0  0
  9 13  2  0  0  0  0
 12 14  2  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
diuron

>  <PRIMARY_SOM>
10 11

>  <Citation>
Abass et al.,Drug Metab. Disp.,35,1634,2007

>  <DOI>
10.1124/dmd.107.016295

$$$$
efavirenz
  MOE2009           3D

 21 23  0  0  1  0  0  0  0  0999 V2000
   -1.8520   -4.1700   -0.4700 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.6250   -0.2560   -2.3270 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8430    1.3560   -2.2090 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.2810    1.7930   -1.9570 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0150    1.9860    0.3760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3180    3.6190    1.2220 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2210    1.5290    1.0160 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7500   -0.7470    1.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0240   -0.3270    0.6270 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5280   -1.7350    0.4800 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1840    0.6660   -0.2070 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.5030   -0.2520    0.7670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9490   -0.2940    0.0770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4630    0.1600    0.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1190    0.1810    0.6660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3160    0.8970   -1.7190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8810   -1.6530   -0.2760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2030   -0.6710    0.9060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1970    2.4430    0.8810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9570   -2.5080   -0.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1180   -2.0170    0.5590 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 20  1  0  0  0  0
  2 16  1  0  0  0  0
  3 16  1  0  0  0  0
  4 16  1  0  0  0  0
  5 11  1  0  0  0  0
  5 19  1  0  0  0  0
  6 19  2  0  0  0  0
  7 15  1  0  0  0  0
  7 19  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
  8 12  1  0  0  0  0
  9 10  1  0  0  0  0
 11 13  1  0  0  0  0
 11 14  1  0  0  0  0
 11 16  1  0  0  0  0
 12 14  3  0  0  0  0
 13 15  2  0  0  0  0
 13 17  1  0  0  0  0
 15 18  1  0  0  0  0
 17 20  2  0  0  0  0
 18 21  2  0  0  0  0
 20 21  1  0  0  0  0
M  END
>  <ID>
efavirenz

>  <PRIMARY_SOM>
21

>  <SECONDARY_SOM>
18

>  <Citation>
Ward et al., J. Pharm. Exp. Ther., 2003, 306, 287-300
Ogburn et al., Drug. Metab. Disp., 2010, 38, 1218-1229

>  <DOI>
10.1124/jpet.103.049601

$$$$
estradiol
  MOE2009           3D

 20 23  0  0  1  0  0  0  0  0999 V2000
   10.3770    3.0490   -0.3030 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2000   -2.8320    0.5680 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5030    1.5170    0.0820 C   0  0  1  0  0  0  0  0  0  0  0  0
    8.4850    0.0120    0.1280 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.2390   -0.7070    0.4930 C   0  0  1  0  0  0  0  0  0  0  0  0
    6.0790   -0.1380   -0.3080 C   0  0  2  0  0  0  0  0  0  0  0  0
    9.8620    1.7620   -0.5710 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.3360    2.0280   -0.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8500   -0.5390   -0.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0140    1.3800   -0.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7010    0.6920    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3070   -2.2050    0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4110    2.0860    1.4870 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7840   -0.8400   -0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0450   -2.8500    0.8600 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7810   -2.1450    0.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5660   -0.2330   -0.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5710   -2.8090    0.6860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3590   -0.8960   -0.1690 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770   -2.1780    0.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  7  1  0  0  0  0
  2 20  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3 13  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  1  0  0  0  0
  5  6  1  0  0  0  0
  5 12  1  0  0  0  0
  6 10  1  0  0  0  0
  6 14  1  0  0  0  0
  7 11  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
 12 15  1  0  0  0  0
 14 16  2  0  0  0  0
 14 17  1  0  0  0  0
 15 16  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  2  0  0  0  0
 18 20  2  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
estradiol

>  <PRIMARY_SOM>
11

>  <Citation>
Lee et al.,Endocrinology,144,3382,2003

>  <DOI>
10.1210/en.2003-0192

$$$$
flunarizine
  MOE2009           3D

 30 33  0  0  0  0  0  0  0  0999 V2000
    1.1440    1.0270   -0.4050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0520    1.8410    0.3850 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3740    1.5800    1.6520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3080    2.4350    2.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3540    1.6840    3.0970 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5200   -0.1190    0.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3420   -0.8620   -0.7080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5860   -0.4640   -2.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0310    0.6770   -2.5260 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8930    1.4180   -1.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7920    1.0170    4.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8400    0.4700    5.2270 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8510    1.4350    5.6710 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2140    2.4610    6.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4430    1.9330    7.6880 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0900    3.6320    6.8630 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4110    2.0580    4.4690 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3930    2.6240    3.4840 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0870    2.2560    7.8010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3380    1.7880    8.8770 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9540    0.9970    9.8410 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2350    0.5440   10.8770 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.3010    0.6670    9.7480 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0450    1.1370    8.6700 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6680    4.9160    6.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4480    6.0260    6.8120 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6530    5.8450    7.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4080    6.9130    7.7760 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.0900    4.5780    7.8490 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3050    3.4710    7.5390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  1  0  0  0  0
  1 10  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5 11  1  0  0  0  0
  5 18  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  1  0  0  0  0
 13 17  1  0  0  0  0
 14 15  1  0  0  0  0
 14 16  1  0  0  0  0
 15 19  1  0  0  0  0
 15 24  2  0  0  0  0
 16 25  1  0  0  0  0
 16 30  2  0  0  0  0
 17 18  1  0  0  0  0
 19 20  2  0  0  0  0
 20 21  1  0  0  0  0
 21 22  1  0  0  0  0
 21 23  2  0  0  0  0
 23 24  1  0  0  0  0
 25 26  2  0  0  0  0
 26 27  1  0  0  0  0
 27 28  1  0  0  0  0
 27 29  2  0  0  0  0
 29 30  1  0  0  0  0
M  END
>  <ID>
flunarizine

>  <PRIMARY_SOM>
4

>  <Citation>
Kariya et al.,Bio. Pharm. Bull.,19,1511,1996

$$$$
flunitrazepam
  MOE2009           3D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -1.6350   -1.0740    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2340   -1.6420   -1.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7690   -2.8630   -1.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7050   -3.5150   -0.8010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1100   -2.9490    0.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5760   -1.7290    0.8090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0760    0.2440    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9190    1.1410    0.7990 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3590    2.4140    1.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9290    3.1980    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2820    2.7990   -0.5340 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3990    0.4450    0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9920    1.6160   -0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3810    1.6130   -0.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1790    0.5170   -0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5750   -0.6080    0.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1990   -0.6590    0.6330 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3850   -1.7650    0.7750 N   0  3  0  0  0  0  0  0  0  0  0  0
   -2.9600   -1.2200    1.9890 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5750    4.1670   -0.3870 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8720    3.6890   -1.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6090   -1.6800    0.6050 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7990   -2.7650    1.2110 O   0  5  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1  7  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  6 19  1  0  0  0  0
  7  8  2  0  0  0  0
  7 12  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 20  2  0  0  0  0
 11 13  1  0  0  0  0
 11 21  1  0  0  0  0
 12 13  1  0  0  0  0
 12 17  2  0  0  0  0
 13 14  2  0  0  0  0
 14 15  1  0  0  0  0
 15 16  2  0  0  0  0
 16 17  1  0  0  0  0
 16 18  1  0  0  0  0
 18 22  2  0  0  0  0
 18 23  1  0  0  0  0
M  CHG  1  18   1
M  CHG  1  23  -1
M  END
>  <ID>
flunitrazepam

>  <PRIMARY_SOM>
21

>  <SECONDARY_SOM>
9

>  <Citation>
Hesse et al.,Drug Metab. Disp.,29,133,2001

$$$$
formononetin
  MOE2009           3D

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0180    1.2780    0.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0750    0.0550   -0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2170    1.8840    0.7740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1360    1.9340    0.9320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1540   -0.6250   -0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3200   -0.5270   -0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3560    1.2390    0.3560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3710    1.3470    0.6850 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4410    0.0630   -0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4780    0.1250    0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0810   -1.7050   -1.1470 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5050    1.9850    1.0920 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7690   -0.4620   -0.6510 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9390    0.2020   -0.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2000   -0.2870   -0.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3150   -1.4580   -1.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1630   -2.1330   -1.7420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9070   -1.6360   -1.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5870   -1.8650   -1.6370 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5840   -3.0690   -2.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  2  0  0  0  0
  5  9  1  0  0  0  0
  5 11  2  0  0  0  0
  6 10  2  0  0  0  0
  7  9  2  0  0  0  0
  8 10  1  0  0  0  0
  8 12  1  0  0  0  0
  9 13  1  0  0  0  0
 13 14  1  0  0  0  0
 13 18  2  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 16 17  2  0  0  0  0
 16 19  1  0  0  0  0
 17 18  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
>  <ID>
formononetin

>  <PRIMARY_SOM>
4 15 17 20

>  <Citation>
Tollesen et al.,J. Agric. Food Chem.,50,4783,2002

>  <DOI>
10.1021/jf025549r

$$$$
halothane
  MOE2009           3D

  7  6  0  0  1  0  0  0  0  0999 V2000
    0.1040   -0.1670    0.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4570   -0.1470    0.4390 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3330    0.7030    1.3300 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3010   -1.4020    0.7590 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3980    0.2250   -0.9860 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.1750    0.2560   -1.0660 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.2770   -1.0090   -2.3420 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
M  END
>  <ID>
halothane

>  <PRIMARY_SOM>
5

>  <Citation>
Spracklin et al.,J. Pharma. Exp. Thera.,281,400,1997

$$$$
hexamethylphosphoramide
  MOE2009           3D

 11 10  0  0  0  0  0  0  0  0999 V2000
   -3.1740    1.8990    1.5740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4010    2.4640    0.4730 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1350    3.5580   -0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7460    2.4890    0.6270 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2700    1.8540    1.9130 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2160    1.6680   -0.7130 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5300    2.1130   -2.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0920    1.0260   -0.6690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2650    4.0880    0.5260 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5890    4.8980    1.7100 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1340    4.3620    0.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4  6  1  0  0  0  0
  4  9  1  0  0  0  0
  6  7  1  0  0  0  0
  6  8  1  0  0  0  0
  9 10  1  0  0  0  0
  9 11  1  0  0  0  0
M  END
>  <ID>
hexamethylphosphoramide

>  <PRIMARY_SOM>
1 3 7 8 10 11

>  <Citation>
T. Su et al., Cancer Res., 2000, 60, 5074-5079

$$$$
ifosfamide
  MOE2009           3D

 14 14  0  0  1  0  0  0  0  0999 V2000
   -0.0210    1.6800    0.0110 P   0  0  3  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  3  0  0  0  0  0  0  0  0  0
    1.4930    2.2300    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7340    2.1720   -1.1880 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8060    2.2240    1.3970 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3810   -0.4440   -0.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7910    3.6920    1.3420 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7710   -0.4020   -1.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3790   -2.1970    0.3810 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.1550    6.0320    1.6430 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.1790    0.1870   -1.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1130    1.7110   -1.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6810   -1.6580    0.6580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1740    4.2310    1.7110 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  2  0  0  0  0
  1  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  8  1  0  0  0  0
  3 12  1  0  0  0  0
  5  7  1  0  0  0  0
  6 13  1  0  0  0  0
  7 14  1  0  0  0  0
  8 11  1  0  0  0  0
  9 13  1  0  0  0  0
 10 14  1  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
ifosfamide

>  <PRIMARY_SOM>
8

>  <Citation>
Roy et al.,Drug Metab. Disp.,27,655,1999

$$$$
indole
  MOE2009           3D

  9 10  0  0  0  0  0  0  0  0999 V2000
    1.4350    4.1220   -4.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5180    3.9210   -3.2280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3570    2.8300   -3.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2760    1.9510   -4.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6330    2.1270   -5.3760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5040    3.2340   -5.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4320    1.0560   -6.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5770    0.2630   -5.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9970    0.8120   -4.6100 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4  9  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
indole

>  <PRIMARY_SOM>
8

>  <SECONDARY_SOM>
7

>  <TERTIARY_SOM>
2

>  <Citation>
Gillam et al., Biochemistry, 2000, 39, 13817-13824

$$$$
lidocaine
  MOE2009           3D

 17 17  0  0  0  0  0  0  0  0999 V2000
    2.4900    1.1150    0.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7430    1.2950   -0.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3920    0.2360   -0.6960 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7890   -1.0080   -0.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5360   -1.1950   -0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8840   -0.1340    0.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6170   -0.3220    0.9770 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4860   -0.1880    0.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8520   -0.2730    0.8450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8780   -0.0120   -0.1730 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1560   -0.4690    0.3880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9750    1.4480   -0.3100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3790    0.0020   -0.9790 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7830    2.2700    1.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8800   -2.5500   -0.2630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2120   -1.9980    0.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0320    1.7920   -1.3610 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1 14  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5 15  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 13  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 12  1  0  0  0  0
 11 16  1  0  0  0  0
 12 17  1  0  0  0  0
M  END
>  <ID>
lidocaine

>  <PRIMARY_SOM>
11 12

>  <Citation>
S. Imaoka et al., Biochemical Pharmacology, 51, 1041-1050,1996

>  <DOI>
10.1016/0006-2952(96)00052-4

$$$$
lisofylline
  MOE2009           3D

 20 21  0  0  1  0  0  0  0  0999 V2000
    3.4700    0.4900   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5560   -0.8940    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1770    1.0770    0.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7360    0.9680   -0.1800 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4690   -1.6380    0.1810 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8560   -1.2610   -0.1520 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1270    0.2770    0.3240 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9900    2.3110    0.1000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5700   -0.1040   -0.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2080    2.3590   -0.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2830   -1.0580    0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5660   -3.1020    0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1630    0.9740    0.5170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3380   -1.8410    0.6160 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2880    0.5400   -0.4570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5380    1.3040    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7960    0.5300   -0.3990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0270    1.3560   -0.0030 C   0  0  3  0  0  0  0  0  0  0  0  0
   -6.2630    0.4680   -0.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9390    1.7590    1.3680 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  3  8  2  0  0  0  0
  4  9  1  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6  9  2  0  0  0  0
  7 11  1  0  0  0  0
  7 13  1  0  0  0  0
 11 14  2  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
lisofylline

>  <PRIMARY_SOM>
18 17

>  <Citation>
Shin and Slattery,J. Pharm. Sci.,87,390,1998

>  <DOI>
10.1021/js970382f

$$$$
lu25_109
  MOE2009           3D

 14 15  0  0  1  0  0  0  0  0999 V2000
   -0.0180    1.4660    0.0100 N   0  0  3  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4280   -0.4820   -1.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6940    0.2260   -1.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1160    1.3030   -1.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3810    1.9050   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5780    1.8740    1.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3680    1.9450   -1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1360    1.5530   -2.6180 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1250    2.3760   -2.7000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0080    3.2760   -1.7880 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9400    3.0440   -1.1040 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2120    2.2980   -3.6800 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8300    3.0930   -4.9300 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  1  0  0  0  0
  1  7  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  8  1  0  0  0  0
  8  9  2  0  0  0  0
  8 12  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  1  0  0  0  0
 10 13  1  0  0  0  0
 11 12  2  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
lu25_109

>  <PRIMARY_SOM>
2 3 6

>  <SECONDARY_SOM>
7

>  <Citation>
K.G. Jensen and L. Dalgaard, Drug Metab. Dispos., 1999, 27, 125-132

$$$$
melatonin
  MOE2009           3D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4020    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3850    1.8270   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2360    2.0840    0.0300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3250   -0.3920   -0.0130 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1990   -0.7060    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1330    0.7120   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8920    3.2460    0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4170    1.3690    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3950   -0.0240    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9580    3.7610    1.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6070    2.0270    0.0620 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4510    5.1410    1.4430 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6300    1.0300    0.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5920    5.8030    2.6080 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0990    7.2220    2.6110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3120    5.2570    3.6540 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5  7  1  0  0  0  0
  6 10  2  0  0  0  0
  8 11  1  0  0  0  0
  9 10  1  0  0  0  0
  9 12  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
 13 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 17  2  0  0  0  0
M  END
>  <ID>
melatonin

>  <PRIMARY_SOM>
10

>  <Citation>
X. C. Ma, J. R. Idle, K. W. Krausz, F. J. Gonzalez, Drug Metab. Dispos. 2005, 33, 489-494.

>  <DOI>
10.1124/dmd.104.002410

$$$$
methiocarb
  MOE2009           3D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -0.0250    1.3690    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0200   -0.0110   -0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1730    2.0590    0.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2040    2.0460    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1770   -0.6990   -0.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3710    1.3730    0.0990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0270    1.9390    1.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3770   -0.0090   -0.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1820   -2.1980   -0.3190 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6710    2.1230    0.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2460    2.5130    1.0470 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6710    1.3240    2.0650 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9050   -0.8860   -0.0730 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1420    2.3960    2.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2500   -0.8580   -1.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  3  6  2  0  0  0  0
  4  7  1  0  0  0  0
  5  8  2  0  0  0  0
  5  9  1  0  0  0  0
  6  8  1  0  0  0  0
  6 10  1  0  0  0  0
  7 11  1  0  0  0  0
  7 12  2  0  0  0  0
  8 13  1  0  0  0  0
 11 14  1  0  0  0  0
 13 15  1  0  0  0  0
M  END
>  <ID>
methiocarb

>  <PRIMARY_SOM>
13

>  <Citation>
Usmani et al.,Drug Metab. Disp.,32,333,2004

>  <DOI>
10.1124/dmd.32.3.333

$$$$
methoxychlor
  MOE2009           3D

 21 22  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1680    0.0620   -0.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3090    2.0860    0.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5780    2.2920   -1.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1900   -0.2880   -1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6790   -0.9090    0.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9300    3.0220   -0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9020    1.6890    1.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2540    1.7310   -1.5320 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.6070    4.0480   -0.7670 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.4660    2.0270   -2.6200 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.3630   -1.6090   -1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5100   -2.2300   -0.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1480    3.5580   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1180    2.2230    1.9830 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5100   -2.5840   -1.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7460    3.1570    1.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6780   -3.8830   -1.4830 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9440    3.6830    1.5420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3400   -4.6320   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2930    3.0800    2.7900 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  1  0  0  0  0
  4 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6 13  2  0  0  0  0
  7 14  1  0  0  0  0
  8 15  2  0  0  0  0
 12 16  2  0  0  0  0
 13 16  1  0  0  0  0
 14 17  2  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  1  0  0  0  0
 18 20  1  0  0  0  0
 19 21  1  0  0  0  0
M  END
>  <ID>
methoxychlor

>  <PRIMARY_SOM>
20 21

>  <Citation>
Hu et al.,Drug Metab. Disp.,30,1035,2002

>  <DOI>
10.1124/dmd.30.9.1035

$$$$
methoxychlor_mono_OH
  MOE2009           3D

 20 21  0  0  1  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.1680    0.0620   -0.3890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3090    2.0860    0.4200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5780    2.2920   -1.1750 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1900   -0.2880   -1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6790   -0.9090    0.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9300    3.0220   -0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9020    1.6890    1.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2540    1.7310   -1.5320 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.6070    4.0480   -0.7670 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.4660    2.0270   -2.6200 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.3630   -1.6090   -1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5100   -2.2300   -0.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1480    3.5580   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1180    2.2230    1.9830 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5100   -2.5840   -1.1230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7460    3.1570    1.1720 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6780   -3.8830   -1.4830 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9440    3.6830    1.5420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3400   -4.6320   -0.8160 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  4 10  1  0  0  0  0
  4 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6 13  2  0  0  0  0
  7 14  1  0  0  0  0
  8 15  2  0  0  0  0
 12 16  2  0  0  0  0
 13 16  1  0  0  0  0
 14 17  2  0  0  0  0
 15 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  1  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
methoxychlor_mono_OH

>  <PRIMARY_SOM>
20

>  <SECONDARY_SOM>
15 14

>  <Citation>
Hu et al.,Drug Metab. Disp.,30,1035,2002

>  <DOI>
10.1124/dmd.30.9.1035

$$$$
montelukast
  MOE2009           3D

 41 45  0  0  1  0  0  0  0  0999 V2000
    1.3780    2.7390    0.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2700    1.4960    0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9000    2.8890    0.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6330    3.0390   -1.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6360    3.1100    1.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2280    4.6290   -1.0920 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4010    2.0600    1.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0000    4.7240   -2.7310 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.2090    2.2020    2.7120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5050    1.0900    0.9370 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0100    3.6150   -2.8750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7000    6.0750   -2.8870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8640    2.6770   -3.8760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0790    3.5360   -2.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6580    7.1950   -2.8650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8010    1.6490   -4.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0110    2.5210   -2.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3360    8.5170   -3.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6520    0.6430   -5.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8810    1.5800   -3.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0140    9.1550   -2.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2740    9.0930   -4.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5550   -0.3440   -5.1980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6360   10.3680   -2.3370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0770    8.5300   -0.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8950   10.3040   -4.6130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4060   -1.3480   -6.2640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5780   10.9410   -3.5930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2660    9.3760    0.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5340    8.4640   -0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5340    7.2100   -0.7850 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3770   -1.2660   -7.0910 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3570   -2.3790   -6.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2040   -2.1570   -8.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2290   -3.3140   -7.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1320   -3.2150   -8.2390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1080   -2.0640   -8.9470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9430   -4.1460   -9.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9550   -2.9850   -9.9390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8710   -4.0240  -10.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4000   -2.8630  -11.0170 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  3  1  0  0  0  0
  4  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  7 10  2  0  0  0  0
  8 11  1  0  0  0  0
  8 12  1  0  0  0  0
 11 13  2  0  0  0  0
 11 14  1  0  0  0  0
 12 15  1  0  0  0  0
 13 16  1  0  0  0  0
 14 17  2  0  0  0  0
 15 18  1  0  0  0  0
 16 19  1  0  0  0  0
 16 20  2  0  0  0  0
 17 20  1  0  0  0  0
 18 21  2  0  0  0  0
 18 22  1  0  0  0  0
 19 23  2  0  0  0  0
 21 24  1  0  0  0  0
 21 25  1  0  0  0  0
 22 26  2  0  0  0  0
 23 27  1  0  0  0  0
 24 28  2  0  0  0  0
 25 29  1  0  0  0  0
 25 30  1  0  0  0  0
 25 31  1  0  0  0  0
 26 28  1  0  0  0  0
 27 32  2  0  0  0  0
 27 33  1  0  0  0  0
 32 34  1  0  0  0  0
 33 35  2  0  0  0  0
 34 36  2  0  0  0  0
 34 37  1  0  0  0  0
 35 36  1  0  0  0  0
 36 38  1  0  0  0  0
 37 39  2  0  0  0  0
 38 40  2  0  0  0  0
 39 40  1  0  0  0  0
 39 41  1  0  0  0  0
M  END
>  <ID>
montelukast

>  <PRIMARY_SOM>
6

>  <Citation>
Chiba et al.,Drug Metab. Dispos.,25,1022,1997

$$$$
nicardipine
  MOE2009           3D

 35 37  0  0  1  0  0  0  0  0999 V2000
    0.4840    1.2560   -0.4290 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.0690   -0.1930   -0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9780    1.4680   -0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0750    1.9000   -1.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7920   -0.5650    0.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5350   -1.1680   -1.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7140    1.9570   -1.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5500    1.1140    1.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7500    2.3970   -2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5410    1.9810   -1.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1640   -1.9000    0.8490 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1510   -2.5010   -1.0670 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1310    2.3860   -2.4610 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2000    2.1000   -1.2360 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5450    1.9680    1.4020 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1310    0.2070    1.7610 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2840    3.0490   -3.8820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9880    1.7490   -3.0090 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2430    2.1700   -0.7680 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7020   -2.8750   -0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0500   -2.2870    1.9280 N   0  3  0  0  0  0  0  0  0  0  0  0
    4.1550    1.6340    2.6500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4110    1.7770   -3.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6020   -1.3850    2.5740 O   0  5  0  0  0  0  0  0  0  0  0  0
   -2.2120   -3.4990    2.1310 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1330    0.4760    2.4940 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2770    0.7730    1.6420 N   0  0  3  0  0  0  0  0  0  0  0  0
    7.0530    1.8480    2.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1050   -0.4220    1.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9580    2.5380    1.2810 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4510    3.5100    0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3160    2.2210    1.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2960    4.1560   -0.4810 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1610    2.8670    0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6500    3.8340   -0.5180 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  4 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 13  1  0  0  0  0
  7 14  1  0  0  0  0
  8 15  1  0  0  0  0
  8 16  2  0  0  0  0
  9 13  1  0  0  0  0
  9 17  1  0  0  0  0
 10 18  1  0  0  0  0
 10 19  2  0  0  0  0
 11 20  2  0  0  0  0
 11 21  1  0  0  0  0
 12 20  1  0  0  0  0
 15 22  1  0  0  0  0
 18 23  1  0  0  0  0
 21 24  1  0  0  0  0
 21 25  2  0  0  0  0
 22 26  1  0  0  0  0
 26 27  1  0  0  0  0
 27 28  1  0  0  0  0
 27 29  1  0  0  0  0
 28 30  1  0  0  0  0
 30 31  2  0  0  0  0
 30 32  1  0  0  0  0
 31 33  1  0  0  0  0
 32 34  2  0  0  0  0
 33 35  2  0  0  0  0
 34 35  1  0  0  0  0
M  CHG  1  21   1
M  CHG  1  24  -1
M  END
>  <ID>
nicardipine

>  <PRIMARY_SOM>
28

>  <Citation>
Nakamura et al.,Biol. Pharm. Bull.,28,882,2005

>  <DOI>
10.1248/bpb.28.882

$$$$
nicotine
  MOE2009           3D

 12 13  0  0  1  0  0  0  0  0999 V2000
    1.1240    0.6150   -0.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1580    1.2470    0.6500 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0140    0.5900    0.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5920   -1.2980    0.4680 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.2680   -0.6650    0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2420   -1.2800   -0.4580 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9790   -0.6390   -0.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7190   -0.9130   -0.3960 N   0  0  3  0  0  0  0  0  0  0  0  0
   -3.2950   -0.5140   -1.7290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5110   -2.1420   -0.5880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1360   -2.9830    0.6130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6360   -2.8070    0.5560 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  7  2  0  0  0  0
  2  3  2  0  0  0  0
  3  5  1  0  0  0  0
  4  5  1  0  0  0  0
  4  8  1  0  0  0  0
  4 12  1  0  0  0  0
  5  6  2  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
nicotine

>  <PRIMARY_SOM>
10

>  <SECONDARY_SOM>
9

>  <TERTIARY_SOM>
4

>  <Citation>
Hukkanen et al, Pharma. Rev.,57,79,2005

>  <DOI>
10.1124/pr.57.1.3

$$$$
o-phenylphenol
  MOE2009           3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -0.9830    2.1830    0.7750 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7520   -0.1310    0.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7250   -0.1760    0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5380    0.9910    0.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4560   -1.2880   -0.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5010    0.9030    0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4190   -1.3300   -0.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9330    0.9640    0.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8480   -1.3320   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8950    0.8450    0.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8120   -1.4060   -0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5890   -0.2000   -0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5500   -0.3140    0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  4  1  0  0  0  0
  2  3  1  0  0  0  0
  2  4  2  0  0  0  0
  2  5  1  0  0  0  0
  3  6  2  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  5  9  2  0  0  0  0
  6 10  1  0  0  0  0
  7 11  2  0  0  0  0
  8 12  2  0  0  0  0
  9 12  1  0  0  0  0
 10 13  2  0  0  0  0
 11 13  1  0  0  0  0
M  END
>  <ID>
o-phenylphenol

>  <PRIMARY_SOM>
9

>  <Citation>
Ozawa et al.,Xenobiotica,30,1005,2000

>  <DOI>
10.1080/00498250050200159

$$$$
omeprazole
  MOE2009           3D

 24 26  0  0  1  0  0  0  0  0999 V2000
   -2.5590    0.5800    0.3960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0690    0.3920    0.5150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3760   -0.5230    0.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7530   -0.3370    0.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2480    0.9650    0.1840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3640    2.0150    0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0670    1.7980    0.4310 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7880   -1.9100    0.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5890   -1.3960    0.0120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7280    1.2220    0.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9630   -1.8010    1.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3220    0.4180   -1.1380 S   0  0  3  0  0  0  0  0  0  0  0  0
    1.3720    0.1840   -0.7120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2140    1.1400   -0.4520 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4310    0.6110   -0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3040   -0.7840   -0.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4000   -1.6000   -0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6120   -1.0380    0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7450    0.3440    0.4240 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6660    1.1690    0.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9870   -1.0240   -0.6020 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9470    0.8860    0.7590 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5840   -0.8140   -1.7960 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.8530   -0.2040    0.9450 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  7  2  0  0  0  0
  2 12  1  0  0  0  0
  3  4  2  0  0  0  0
  3  8  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  1  0  0  0  0
  5  6  2  0  0  0  0
  5 10  1  0  0  0  0
  6  7  1  0  0  0  0
  9 11  1  0  0  0  0
 12 13  1  0  0  0  0
 12 23  2  0  0  0  0
 13 14  2  0  0  0  0
 13 21  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 20  2  0  0  0  0
 16 17  2  0  0  0  0
 16 21  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  2  0  0  0  0
 19 20  1  0  0  0  0
 19 22  1  0  0  0  0
 22 24  1  0  0  0  0
M  END
>  <ID>
omeprazole

>  <PRIMARY_SOM>
10

>  <Citation>
Abelo et al.,Drug Metab. Disp.,28,966,2000

$$$$
oxycodone
  MOE2009           3D

 23 27  0  0  1  0  0  0  0  0999 V2000
   -0.2940    1.5470   -0.1680 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.5160    0.0620   -0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2090    1.7270   -0.0160 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.1640    1.8480    1.0420 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.7710    2.2670   -1.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6920   -0.2610    0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3400   -0.8350   -0.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8700    1.1380   -1.2620 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.7020    1.0060    1.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5160    3.1200    0.0760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2070    0.8330    0.9350 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4410    1.6050    2.3340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0070    1.6840   -2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1160   -1.5940    0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6560   -0.3550   -1.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0940   -2.1490   -0.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4340    1.8770   -2.4490 N   0  0  3  0  0  0  0  0  0  0  0  0
    1.0510    1.6530    2.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0940    1.3580    3.3200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2960   -2.5020   -0.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2750   -1.9870    0.8920 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0870    1.2470   -3.6040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3980   -3.3930    0.6690 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  1  0  0  0  0
  2  6  2  0  0  0  0
  2  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  1  0  0  0  0
  3 10  1  0  0  0  0
  4 11  1  0  0  0  0
  4 12  1  0  0  0  0
  5 13  1  0  0  0  0
  6 11  1  0  0  0  0
  6 14  1  0  0  0  0
  7 15  1  0  0  0  0
  7 16  2  0  0  0  0
  8 15  1  0  0  0  0
  8 17  1  0  0  0  0
  9 18  1  0  0  0  0
 12 18  1  0  0  0  0
 12 19  2  0  0  0  0
 13 17  1  0  0  0  0
 14 20  2  0  0  0  0
 14 21  1  0  0  0  0
 16 20  1  0  0  0  0
 17 22  1  0  0  0  0
 21 23  1  0  0  0  0
M  END
>  <ID>
oxycodone

>  <PRIMARY_SOM>
22

>  <Citation>
Lalovic et al.,Drug Metab. Disp.,32,447,2004

>  <DOI>
10.1124/dmd.32.4.447

$$$$
perazine
  MOE2009           3D

 24 27  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3900    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1420    2.1590    0.1180 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0040    0.0000   -0.1020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3130    2.0730    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3540    1.7290   -0.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0680    3.3850    0.7710 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0890   -0.6710   -0.6520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0960   -0.7200    0.3520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8160    2.1910    1.4600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5050    0.1890   -1.2380 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.4820    2.5340   -0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1940    4.1760    0.8990 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0610   -2.0600   -0.7420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1140   -2.0990    0.2580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1700    2.9040    1.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4010    3.7500    0.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0350   -2.7680   -0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6530    3.0180    2.8520 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8170    3.9120    2.8200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1460    1.6890    3.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4500    3.9810    4.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7790    1.7590    4.6280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9440    2.6530    4.5960 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4270    2.7670    5.9780 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 10  1  0  0  0  0
  7 13  1  0  0  0  0
  8 14  2  0  0  0  0
  9 15  1  0  0  0  0
 11 16  2  0  0  0  0
 12 16  1  0  0  0  0
 13 17  2  0  0  0  0
 14 17  1  0  0  0  0
 15 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 20  1  0  0  0  0
 19 21  1  0  0  0  0
 20 22  1  0  0  0  0
 21 23  1  0  0  0  0
 22 23  1  0  0  0  0
 23 24  1  0  0  0  0
M  END
>  <ID>
perazine

>  <PRIMARY_SOM>
10

>  <Citation>
Wojcikowski et al.,Europ. Neuropsychopharm.,14,199,2004

>  <DOI>
10.1016/S0924-977X(03)00105-6

$$$$
phenacetin
  MOE2009           2D

 13 13  0  0  0  0  0  0  0  0999 V2000
    2.8660   -2.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5980    2.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    2.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660    1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8660   -1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0000   -3.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320    3.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  5  1  0  0  0  0
  1 10  1  0  0  0  0
  2 12  2  0  0  0  0
  3  4  1  0  0  0  0
  3 12  1  0  0  0  0
  4  6  2  0  0  0  0
  4  7  1  0  0  0  0
  5  8  2  0  0  0  0
  5  9  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  2  0  0  0  0
 10 11  1  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
phenacetin

>  <PRIMARY_SOM>
10

>  <Citation>
M. Nakajima et al., Xenobiotica, 1999, 29, 885-898

>  <DOI>
10.1080/004982599238137

$$$$
phenytoin
  MOE2009           3D

 19 21  0  0  0  0  0  0  0  0999 V2000
   -0.0570    1.5580    0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2250    0.2250    0.2410 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4370    1.7730   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9440   -0.4240    0.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9900    0.4090    0.0580 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9220    2.4070    0.1260 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0490   -1.6320    0.2820 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7660    2.4210   -1.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9550    2.6060    1.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7410    1.8750   -2.1360 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0900    3.5590   -1.7210 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0640    2.1880    1.8550 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3250    3.7900    1.4760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3920    4.1530   -2.9320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5380    2.9510    2.9050 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8000    4.5530    2.5260 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0430    2.4700   -3.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3710    3.6110   -3.7440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9050    4.1330    3.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  6  2  0  0  0  0
  2  4  1  0  0  0  0
  3  5  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  1  0  0  0  0
  4  5  1  0  0  0  0
  4  7  2  0  0  0  0
  8 10  2  0  0  0  0
  8 11  1  0  0  0  0
  9 12  2  0  0  0  0
  9 13  1  0  0  0  0
 10 17  1  0  0  0  0
 11 14  2  0  0  0  0
 12 15  1  0  0  0  0
 13 16  2  0  0  0  0
 14 18  1  0  0  0  0
 15 19  2  0  0  0  0
 16 19  1  0  0  0  0
 17 18  2  0  0  0  0
M  END
>  <ID>
phenytoin

>  <PRIMARY_SOM>
14 15 16 17 18 19

>  <Citation>
Komatsu et al.,Drug Metab. Disp.,28,1361,2000

$$$$
phorate
  MOE2009           3D

 13 12  0  0  0  0  0  0  0  0999 V2000
    0.0600    1.8750   -0.0690 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2770   -0.1900   -0.4090 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.6440    2.1570   -0.0060 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5900    2.7300   -1.2680 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7240    2.3750    1.5460 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.4140   -0.3510   -2.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1000    1.6730    1.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0060    2.6970   -1.0790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2260   -0.3430   -1.9850 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.6060    1.9120    1.3840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6950    3.3750   -2.2650 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5160   -2.0150   -1.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0200   -2.2440   -1.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  1  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4  8  1  0  0  0  0
  6  9  1  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
  9 12  1  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
phorate

>  <PRIMARY_SOM>
9

>  <Citation>
Usmani et al.,Drug Metab. Disp.,32,333,2004

>  <DOI>
10.1124/dmd.32.3.333

$$$$
pilocarpine
  MOE2009           3D

 15 16  0  0  1  0  0  0  0  0999 V2000
   -4.3820    1.7090    4.2210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0910    1.1650    3.6210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6300    1.9490    2.3860 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.2920    1.5110    1.7830 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.7130    0.3990    0.8440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9900    0.8050    0.3480 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5510    1.7020    1.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6520    2.2050    1.0530 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1930    1.1080    2.7690 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1170    0.8870    2.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9810    1.7850    1.4890 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0800    1.1530    0.9710 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9060   -0.1170    1.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7410   -0.3290    1.9350 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2780   -1.6130    2.4010 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  7  1  0  0  0  0
  4  5  1  0  0  0  0
  4  9  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 10 14  1  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
M  END
>  <ID>
pilocarpine

>  <PRIMARY_SOM>
3

>  <Citation>
T. Endo et al., Drug Metab. Dispos., 2007, 35, 476-483

>  <DOI>
10.1124/dmd.106.012425

$$$$
progesterone
  MOE2009           3D

 23 26  0  0  1  0  0  0  0  0999 V2000
   -4.1190   -0.9300    0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8210   -0.8520    0.3280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8730    0.2870   -0.2860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2900    1.5940    0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9070    0.2500   -0.9180 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8180    1.6240   -0.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0530    0.4340    0.3550 C   0  0  3  0  0  0  0  0  0  0  0  0
   -2.0940   -2.1420    0.6620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6850    0.7350    1.8090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7430    0.2750   -0.4260 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.0320   -0.9350    0.1160 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.8030   -2.2060   -0.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0730    1.5580   -0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4530    1.4210   -0.9630 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1510    0.2480   -0.3020 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.3440   -1.0170   -0.6420 C   0  0  3  0  0  0  0  0  0  0  0  0
    2.3080   -2.1190   -0.1870 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5540   -0.0800   -0.8020 C   0  0  3  0  0  0  0  0  0  0  0  0
    3.6870   -1.6000   -0.6790 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1750    0.4470    1.2150 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5880    0.5950    0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0240    2.0040   -0.2450 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0660    0.0060    1.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  2  7  1  0  0  0  0
  2  8  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  2  0  0  0  0
  4  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  9  1  0  0  0  0
  7 10  1  0  0  0  0
  8 12  1  0  0  0  0
 10 11  1  0  0  0  0
 10 13  1  0  0  0  0
 11 12  1  0  0  0  0
 11 16  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  0  0  0  0
 15 18  1  0  0  0  0
 15 20  1  0  0  0  0
 16 17  1  0  0  0  0
 17 19  1  0  0  0  0
 18 19  1  0  0  0  0
 18 21  1  0  0  0  0
 21 22  1  0  0  0  0
 21 23  2  0  0  0  0
M  END
>  <ID>
progesterone

>  <PRIMARY_SOM>
8

>  <Citation>
T. Niwa, Y. Yabusaki, K. Honma, N. Matsuo, K. Tatsuta, F. Ishibashi, M. Katagiri, Xenobiotica 1998, 28, 539-547. Links  

>  <DOI>
10.1080/004982598239290

$$$$
promazine
  MOE2009           3D

 20 22  0  0  0  0  0  0  0  0999 V2000
    0.0430    1.5840    0.0510 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1520    2.4400    0.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0690    0.1900   -0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2720    2.2060    0.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4690    1.9520    0.1590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9770    3.8260    0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2760   -0.5260   -0.1940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1230   -0.5360   -0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7560    2.2410    1.5560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8770    0.2290   -0.0190 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.5500    2.8320    0.2860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0540    4.7000    0.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2660   -1.9130   -0.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1310   -1.9160   -0.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1070    2.9140    1.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3470    4.2000    0.4310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0700   -2.6070   -0.5380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6150    2.9690    2.9600 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7940    3.8840    3.7350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9430    3.5530    2.8930 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  2  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  1  0  0  0  0
  5 10  1  0  0  0  0
  5 11  1  0  0  0  0
  6 12  2  0  0  0  0
  7 10  1  0  0  0  0
  7 13  1  0  0  0  0
  8 14  2  0  0  0  0
  9 15  1  0  0  0  0
 11 16  2  0  0  0  0
 12 16  1  0  0  0  0
 13 17  2  0  0  0  0
 14 17  1  0  0  0  0
 15 18  1  0  0  0  0
 18 19  1  0  0  0  0
 18 20  1  0  0  0  0
M  END
>  <ID>
promazine

>  <PRIMARY_SOM>
10

>  <Citation>
Wojcikowski et al.,Br. J. Pharm.,138,1465,2003

>  <DOI>
10.1038/sj.bjp.0705195

$$$$
propofol
  MOE2009           3D

 13 13  0  0  0  0  0  0  0  0999 V2000
    1.2200    0.7140    0.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5030    1.4740    0.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1970    1.1810    1.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4290    1.1690   -0.9080 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0040    1.3940    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020    2.7620    0.0030 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2100    0.7100   -0.1010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4950    1.4650   -0.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1880    1.1570   -1.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4210    1.1700    0.9310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1930   -0.6880   -0.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0070   -1.3830    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2060   -0.6840    0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  5  1  0  0  0  0
  1 13  2  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  2  0  0  0  0
  7  8  1  0  0  0  0
  7 11  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
propofol

>  <PRIMARY_SOM>
12

>  <Citation>
Court et al.,Anesthesiology,94,110,2001
J. Guitton, T. Buronfosse, M. Desage, J. P. Flinois, J. P. Perdrix, J. L. Brazier, P. Beaune, Br. J. Anaesth. 1998, 80, 788-795.

$$$$
psoralen
  MOE2009           3D

 14 16  0  0  0  0  0  0  0  0999 V2000
    1.2550    0.6610    0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0700    1.4030    0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0910    0.6410   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1180   -0.7440   -0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0960   -1.4510   -0.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2850   -0.7260   -0.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5620   -1.4120   -0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6890   -0.7130    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6970    0.7460    0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7500    1.3640    0.3180 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4620    1.3880    0.2150 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3590    1.1380   -0.0280 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2050    0.0780   -0.1630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4870   -1.0960   -0.2360 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  1 11  1  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  3 12  1  0  0  0  0
  4  5  2  0  0  0  0
  4 14  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  2  0  0  0  0
  9 11  1  0  0  0  0
 12 13  1  0  0  0  0
 13 14  2  0  0  0  0
M  END
>  <ID>
psoralen

>  <PRIMARY_SOM>
13 14

>  <Citation>
L.L. Koenigs and W.F. Trager, Biochemistry, 37, 10047-10061

$$$$
quinoline
  MOE2009           3D

 10 11  0  0  0  0  0  0  0  0999 V2000
    0.0210    0.6400   -0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400   -0.7540   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1670    1.3900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1470    1.3740    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1440   -1.4600   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2090   -1.4360   -0.0240 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3660    0.6780   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3440    0.6720   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3440   -0.7300    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3580   -0.7260    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  4  8  2  0  0  0  0
  5  9  2  0  0  0  0
  6 10  2  0  0  0  0
  7 10  1  0  0  0  0
  8  9  1  0  0  0  0
M  END
>  <ID>
quinoline

>  <PRIMARY_SOM>
4 8

>  <SECONDARY_SOM>
6

>  <TERTIARY_SOM>
7

>  <Citation>
G. Reigh et al., Carcinogenesis, 1996, 17, 1989-1996

$$$$
rabeprazole_thioether
  MOE2009           3D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -0.0830    1.2680    0.1050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1220   -0.0140   -0.1760 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1930    1.7400    0.1980 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4260    2.3220    0.3360 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1100    1.6960    0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7460    1.0830    0.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7120    1.9050   -1.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2000   -0.3900   -0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0430    0.6940   -0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7080    2.0160    1.3870 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9840    2.4790   -1.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9380    2.5700    1.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6120    2.8200    0.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5470    2.6750   -2.2920 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.3580    3.4700   -3.6020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0170    1.5260   -2.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7590   -1.6470   -0.5450 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1890    4.2790   -4.8740 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4350    0.6110   -0.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8340    3.2750   -2.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7230    4.1080   -3.5460 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.4720    4.8780   -4.7920 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9680   -0.6510   -0.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1520   -1.7570   -0.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  8  1  0  0  0  0
  3  9  1  0  0  0  0
  4  6  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  2  0  0  0  0
  5 10  1  0  0  0  0
  7 11  1  0  0  0  0
  7 16  1  0  0  0  0
  8  9  2  0  0  0  0
  8 17  1  0  0  0  0
  9 19  1  0  0  0  0
 10 12  2  0  0  0  0
 11 13  2  0  0  0  0
 11 14  1  0  0  0  0
 12 13  1  0  0  0  0
 14 20  1  0  0  0  0
 15 20  1  0  0  0  0
 15 21  1  0  0  0  0
 17 24  2  0  0  0  0
 18 21  1  0  0  0  0
 18 22  1  0  0  0  0
 19 23  2  0  0  0  0
 23 24  1  0  0  0  0
M  END
>  <ID>
rabeprazole_thioether

>  <PRIMARY_SOM>
4 22

>  <Citation>
Miura et al.,Eur. J. Clin. Pharmacol.,62,113,2006

>  <DOI>
10.1007/s00228-005-0077-8

$$$$
safrole
  MOE2009           3D

 12 13  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.5030    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3950    2.0240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6310   -0.6730    0.9340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0310    2.2700   -1.2030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0520    2.2620    1.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3310    2.7490   -1.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3490    2.7410    1.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9940    2.9830   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1690    3.0660   -2.2450 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2480    3.4470   -0.2900 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2030    3.8820   -1.6620 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  2  4  2  0  0  0  0
  3  5  2  0  0  0  0
  3  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  2  0  0  0  0
  7  9  2  0  0  0  0
  7 10  1  0  0  0  0
  8  9  1  0  0  0  0
  9 11  1  0  0  0  0
 10 12  1  0  0  0  0
 11 12  1  0  0  0  0
M  END
>  <ID>
safrole

>  <PRIMARY_SOM>
1

>  <Citation>
Ueng et al.,Chem. Res. Toxicol.,17,1151,2004

>  <DOI>
10.1021/tx030055p

$$$$
selegiline
  MOE2009           3D

 14 14  0  0  1  0  0  0  0  0999 V2000
    3.7100    1.4800    0.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9440    0.2810   -0.6040 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9200   -0.6550   -0.7320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6560   -0.4050   -0.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4320    0.8000    0.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4530    1.7400    0.6010 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6060   -1.4520   -0.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7660   -1.2830    0.2630 C   0  0  3  0  0  0  0  0  0  0  0  0
   -1.5700   -0.1870   -0.2590 N   0  0  3  0  0  0  0  0  0  0  0  0
   -0.6710   -1.2840    1.7740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7140   -0.3550   -1.6990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6520    0.9880    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2720    2.0080    0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9040   -0.2580    0.3220 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  6  2  0  0  0  0
  2  3  2  0  0  0  0
  3  4  1  0  0  0  0
  4  5  2  0  0  0  0
  4  7  1  0  0  0  0
  5  6  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
  9 11  1  0  0  0  0
  9 14  1  0  0  0  0
 12 13  3  0  0  0  0
 12 14  1  0  0  0  0
M  END
>  <ID>
selegiline

>  <PRIMARY_SOM>
14

>  <SECONDARY_SOM>
11

>  <Citation>
Benetton et al., Drug Metab. Pharma.,2,78,2007

>  <DOI>
10.2133/dmpk.22.78

$$$$
sertraline
  MOE2009           3D

 20 22  0  0  1  0  0  0  0  0999 V2000
   -2.6400    8.7890    2.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3890    7.7420    1.9960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3700    8.5450    3.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8700    6.4500    1.9900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6020    6.1870    2.5170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8450    7.2490    3.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0550    4.7890    2.4670 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.5370    7.0210    3.5880 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.2020    5.9260    2.7660 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4210    4.6270    2.8020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8650    3.7630    3.1980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5970    2.8260    2.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3650    1.8690    3.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9120    3.7320    4.5950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6790    2.7760    5.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4080    1.8420    4.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5260    6.6110    4.9900 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3830    0.6260    5.2570 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.6750    2.8170    6.9810 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.2510    7.7690    5.8230 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  2  4  1  0  0  0  0
  3  6  2  0  0  0  0
  4  5  2  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  6  8  1  0  0  0  0
  7 10  1  0  0  0  0
  7 11  1  0  0  0  0
  8  9  1  0  0  0  0
  8 17  1  0  0  0  0
  9 10  1  0  0  0  0
 11 12  2  0  0  0  0
 11 14  1  0  0  0  0
 12 13  1  0  0  0  0
 13 16  2  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 15 19  1  0  0  0  0
 16 18  1  0  0  0  0
 17 20  1  0  0  0  0
M  END
>  <ID>
sertraline

>  <PRIMARY_SOM>
20

>  <Citation>
Obach et al.,Drug Metab. Disp.,33,262,2005
Kobayashi et al.,Drug Metab. Disp.,27,763,1999

>  <DOI>
10.1124/dmd.104.002428

$$$$
styrene
  MOE2009           3D

  8  8  0  0  0  0  0  0  0  0999 V2000
    1.1560    0.6760   -0.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0180    1.4440   -0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0500    2.8720   -0.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9550    3.5830   -0.8700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1130    0.8270    0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1080   -0.5390    0.7190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0300   -1.2970    0.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1630   -0.6900   -0.0740 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  8  2  0  0  0  0
  2  3  1  0  0  0  0
  2  5  2  0  0  0  0
  3  4  2  0  0  0  0
  5  6  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
M  END
>  <ID>
styrene

>  <PRIMARY_SOM>
3 4

>  <Citation>
Nakajima et al.,Chem. Res. Toxicol.,7,891,1994

>  <DOI>
10.1021/tx00042a026

$$$$
tegafur
  MOE2009           3D

 14 15  0  0  1  0  0  0  0  0999 V2000
    6.6960   -0.3830    0.8750 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.1880   -0.4070    2.4460 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1800   -4.3660    1.8820 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4870   -2.9820    0.9680 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5860   -2.0840    1.5970 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3240   -3.6770    1.4260 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2240   -1.6940    1.8100 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.4360   -1.5700    0.5190 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4310   -0.5020    0.8700 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2530    0.4220    1.7400 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9590   -3.4380    1.6540 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5070   -1.0880    1.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7950   -1.3500    1.1280 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3030   -2.7300    1.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 13  1  0  0  0  0
  2  7  1  0  0  0  0
  2 10  1  0  0  0  0
  3 11  2  0  0  0  0
  4 14  2  0  0  0  0
  5  7  1  0  0  0  0
  5 11  1  0  0  0  0
  5 12  1  0  0  0  0
  6 11  1  0  0  0  0
  6 14  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
M  END
>  <ID>
tegafur

>  <PRIMARY_SOM>
7

>  <Citation>
Komatsu, T.; Yamazaki, H.; Shimada, N.; Nakajima, M.; Yokoi, T. Roles of Cytochromes P450 1A2 2A6, and 2C8 in 5-Fluorouracil Formation from Tegafur, an Anticancer Prodrug, in Human Liver Microsomes. Drug Metab. Dispos. 2000, 28, 1457~1463. 

$$$$
theophylline
  MOE2009           3D

 13 14  0  0  0  0  0  0  0  0999 V2000
    1.2130    0.5920    0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0370    1.3820    0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0200    2.5990    0.2840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0930    0.6030   -0.1330 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3450    1.3030   -0.2500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1340   -0.7960   -0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1870   -1.3920   -0.5480 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0870   -1.4650   -0.1920 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1180   -2.8950   -0.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2350   -0.7620    0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4890   -1.2730    0.2160 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2420   -0.2170    0.4630 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5020    0.9400    0.4830 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1 10  2  0  0  0  0
  1 13  1  0  0  0  0
  2  3  2  0  0  0  0
  2  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  6  1  0  0  0  0
  6  7  2  0  0  0  0
  6  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <ID>
theophylline

>  <PRIMARY_SOM>
12

>  <Citation>
Zhang and Kaminsky,Biochem. Pharmacol.,50,205,1995

>  <DOI>
10.1016/0006-2952(95)00120-O

$$$$
thioridazine
  MOE2009           3D

 25 28  0  0  1  0  0  0  0  0999 V2000
   -0.9640    0.8750    0.5140 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1490   -0.4900    0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9660   -0.9560    1.9930 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.2420    1.4560    0.8990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3440   -1.4430    0.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2170    0.7390    1.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1130    1.7600    0.3090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4150    3.5460   -2.7700 N   0  0  3  0  0  0  0  0  0  0  0  0
   -2.1700   -0.9020   -0.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1330    2.2420   -1.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3120    3.1940   -1.3480 C   0  0  3  0  0  0  0  0  0  0  0  0
   -0.5680   -2.7940    0.6940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3880   -2.2540   -0.7700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6850   -2.7690   -1.8460 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5840   -3.2010   -0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4880    2.3410   -3.6070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5630    4.4280   -3.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4720    2.7920    0.5860 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4030    1.3590    1.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0930    4.4630   -0.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5550   -4.5780   -1.8060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3800    5.7340   -2.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6560    3.4020    0.9560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6200    2.6890    1.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2650    5.4220   -0.7460 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  4  1  0  0  0  0
  1  7  1  0  0  0  0
  2  5  2  0  0  0  0
  2  9  1  0  0  0  0
  3  5  1  0  0  0  0
  3  6  1  0  0  0  0
  4  6  2  0  0  0  0
  4 18  1  0  0  0  0
  5 12  1  0  0  0  0
  6 19  1  0  0  0  0
  7 10  1  0  0  0  0
  8 11  1  0  0  0  0
  8 16  1  0  0  0  0
  8 17  1  0  0  0  0
  9 13  2  0  0  0  0
 10 11  1  0  0  0  0
 11 20  1  0  0  0  0
 12 15  2  0  0  0  0
 13 14  1  0  0  0  0
 13 15  1  0  0  0  0
 14 21  1  0  0  0  0
 17 22  1  0  0  0  0
 18 23  2  0  0  0  0
 19 24  2  0  0  0  0
 20 25  1  0  0  0  0
 22 25  1  0  0  0  0
 23 24  1  0  0  0  0
M  END
>  <ID>
thioridazine

>  <PRIMARY_SOM>
3

>  <Citation>
Wojcikowski et al.,Drug Metab. Disp.,34,471,2006

>  <DOI>
10.1124/dmd.105.006445

$$$$
valproic_acid
  MOE2009           3D

 10  9  0  0  0  0  0  0  0  0999 V2000
   -0.5060   -0.6040   -0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8340   -0.0150   -0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2450   -0.3530    1.3440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0680   -1.8050    1.7180 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7920   -2.8300    0.8760 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1440   -2.4530    0.3130 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0930   -1.8780    1.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2720   -2.0240    3.1840 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1410   -2.5360    3.7290 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2910   -1.7850    3.8120 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4  8  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  2  0  0  0  0
M  END
>  <ID>
valproic_acid

>  <PRIMARY_SOM>
2 6

>  <SECONDARY_SOM>
1 3 5 7

>  <Citation>
Kiang et al., Toxicological Sciences, 2006, 94, 261-271

>  <DOI>
10.1093/toxsci/kfl096

$$$$
zotepine
  MOE2009           3D

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.3360    1.9550   -0.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4180    0.5680   -0.6020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4970    2.8440   -0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9350    2.5460   -0.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9420   -0.3530   -0.6610 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7550   -0.1860   -0.7370 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6110    2.8100   -0.9440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3280    3.8820    0.6920 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0900    1.7860   -0.4850 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8010    0.5030   -1.9670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0080    0.4160   -0.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0330    1.8850   -1.9790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4230    3.3140    1.9980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6250    2.5460   -0.4110 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.3080   -0.2880   -3.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7900    2.4390   -3.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7350    4.2160    3.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0410    0.2780   -4.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2850    1.6450   -4.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7180    4.1450    2.9580 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1410    2.8340    3.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2230    5.1130    3.9140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  0  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  3  7  2  0  0  0  0
  3  8  1  0  0  0  0
  4  9  2  0  0  0  0
  5 10  1  0  0  0  0
  6 11  2  0  0  0  0
  7 12  1  0  0  0  0
  8 13  1  0  0  0  0
  9 11  1  0  0  0  0
  9 14  1  0  0  0  0
 10 12  2  0  0  0  0
 10 15  1  0  0  0  0
 12 16  1  0  0  0  0
 13 17  1  0  0  0  0
 15 18  2  0  0  0  0
 16 19  2  0  0  0  0
 17 20  1  0  0  0  0
 18 19  1  0  0  0  0
 20 21  1  0  0  0  0
 20 22  1  0  0  0  0
M  END
>  <ID>
zotepine

>  <PRIMARY_SOM>
22 21

>  <Citation>
Shigura et al.,Xenobiotica,29,217,1999

>  <DOI>
10.1080/004982599238623

$$$$
